NCT05721976
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study No drug interventions treatment Not Available recruiting NCT05059782
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT03030287
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer treatment 1 completed NCT03936075
Guided Imagery & Music in Cancer No drug interventions supportive_care Not Available unknown_status NCT04258813
Onco-primary Care Networking to Support TEAM-based Care No drug interventions prevention Not Available recruiting NCT05154474
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy No drug interventions Not Available Not Available unknown_status NCT02107950
Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma treatment 2 completed NCT01847677
Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin treatment 2 terminated NCT03400306
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer treatment 1 withdrawn NCT06583395
Quest to Analyze One Thousand Humans Meditating No drug interventions Not Available Not Available enrolling_by_invitation NCT04971304
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars Not Available Not Available completed NCT02991677
Exercise Effect on Chemotherapy-Induced Neuropathic Pain No drug interventions treatment Not Available active_not_recruiting NCT06376604
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies No drug interventions supportive_care Not Available recruiting NCT05939440
Interventions to Decrease Financial Toxicity No drug interventions supportive_care Not Available active_not_recruiting NCT04726319
Family History App in Personalized Medicine No drug interventions screening Not Available active_not_recruiting NCT03653819
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs No drug interventions supportive_care Not Available completed NCT05887531
Abdominopelvic Cancer Prehabilitation No drug interventions supportive_care Not Available recruiting NCT03667417
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation No drug interventions Not Available Not Available recruiting NCT02432378
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines treatment 1 / 2 recruiting NCT02582931
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer No drug interventions treatment 1 completed NCT02063464
Blood Collection From People With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00327171
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer treatment 2 completed NCT01535157
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT02669914
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors treatment 2 terminated NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT06161233
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy No drug interventions supportive_care Not Available completed NCT02997553
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery diagnostic 3 completed NCT04532645
Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK Not Available Not Available active_not_recruiting NCT00193297
Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma treatment 2 completed NCT05763511
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker No drug interventions Not Available Not Available recruiting NCT05080556
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer treatment 2 recruiting NCT06497270
the DISC-OVARY Trial No drug interventions prevention Not Available not_yet_recruiting NCT05561413
Gynaecology Exercise and Mindfulness Study No drug interventions supportive_care Not Available unknown_status NCT04523116
Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 No drug interventions Not Available Not Available unknown_status NCT03199586
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies treatment 1 completed NCT05990426
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy No drug interventions supportive_care Not Available recruiting NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy No drug interventions treatment 2 recruiting NCT05081765
The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib Not Available Not Available unknown_status NCT03011320
An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery basic_science 1 completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT03162562
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer treatment 1 terminated NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT06256055
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT06329323
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours No drug interventions Not Available Not Available not_yet_recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination With IV DFMO treatment 1 / 2 suspended NCT05200364
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer treatment 1 active_not_recruiting NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers treatment 1 / 2 recruiting NCT02552121
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT03740984
Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy No drug interventions supportive_care Not Available terminated NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) No drug interventions Not Available Not Available recruiting NCT03384511
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. treatment 4 completed NCT05887609
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib treatment 2 recruiting NCT06556342
The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women No drug interventions diagnostic Not Available recruiting NCT03245736
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. treatment 2 completed NCT05743517
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) No drug interventions supportive_care Not Available recruiting NCT02069158
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor treatment 1 completed NCT03748186
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers treatment 1 completed NCT06331130
Mesenteric Infiltration in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05677048
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention No drug interventions health_services_research Not Available recruiting NCT04205227
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors treatment 1 / 2 active_not_recruiting NCT05256576
KORE-Innovation: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients With Ovarian Cancer No drug interventions health_services_research Not Available recruiting NCT04000880
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health No drug interventions supportive_care Not Available active_not_recruiting NCT06540729
Disitamab Vedotin (RC48) in Combination With AK104 (PD-1/CTLA-4 Bispecific) and Bevacizumab for the Treatment of Recurrent and Persistent Clear Cell Ovarian Cancer: a Single-arm, Phase II, Multicenter Study (DAB OCC Study) treatment 2 not_yet_recruiting NCT03593681
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy No drug interventions Not Available Not Available completed NCT02001623
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT05187338
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors treatment 1 / 2 recruiting NCT05465590
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer No drug interventions treatment 0 withdrawn NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) No drug interventions Not Available Not Available completed NCT06478862
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy treatment 2 recruiting NCT01595204
Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer Patients No drug interventions treatment Not Available completed NCT05246462
The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients No drug interventions supportive_care Not Available completed NCT02704650
Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids No drug interventions diagnostic Not Available withdrawn NCT04438564
Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients No drug interventions supportive_care Not Available recruiting NCT00478387
Ovarian Cancer and Immune Response to Flu Vaccine No drug interventions Not Available Not Available completed NCT03759587
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer treatment 2 completed NCT04908787
A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer treatment 3 active_not_recruiting NCT02429687
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors treatment 3 recruiting NCT00002487
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer treatment 2 unknown_status NCT04945187
Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study) No drug interventions supportive_care Not Available recruiting NCT05787587
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03641287
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors No drug interventions supportive_care Not Available terminated NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation No drug interventions treatment 2 completed NCT05973487
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT01034033
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples No drug interventions Not Available Not Available recruiting NCT05142033
Avera Cancer Sequencing and Analytics Protocol (ASAP) No drug interventions Not Available Not Available recruiting NCT00870233
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life No drug interventions Not Available Not Available completed NCT03056833
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer treatment 1 completed NCT00662233
Combination Chemotherapy in Treating Patients With Sarcoma treatment 0 completed NCT05220033
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer No drug interventions supportive_care Not Available recruiting NCT04402333
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival No drug interventions Not Available Not Available unknown_status NCT00337233
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer No drug interventions supportive_care Not Available completed NCT03117933
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer treatment 2 completed NCT03448354
Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT01281254
AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) treatment 3 terminated NCT00369954
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin treatment 2 withdrawn NCT02517554
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services No drug interventions Not Available Not Available completed NCT05620654
A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin treatment 1 recruiting NCT06468254
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer No drug interventions prevention 2 recruiting NCT00550654
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain No drug interventions treatment 2 terminated NCT00444054
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer No drug interventions treatment Not Available completed NCT01220154
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer treatment 1 unknown_status NCT01016054
A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer treatment 1 terminated NCT00431054
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer treatment 1 completed NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients No drug interventions Not Available Not Available completed NCT05287451
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study No drug interventions prevention Not Available recruiting NCT01037751
M. D. Anderson Symptom Inventory - Ovarian Cancer No drug interventions Not Available Not Available completed NCT01267851
Clinical Database and Biobank of Patients With Gynecologic Neoplasms No drug interventions Not Available Not Available unknown_status NCT04614051
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC) No drug interventions treatment 1 terminated NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT01881451
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer No drug interventions Not Available Not Available terminated NCT00066651
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00856453
Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer No drug interventions supportive_care Not Available terminated NCT06376253
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers treatment 1 not_yet_recruiting NCT05952453
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro treatment 2 not_yet_recruiting NCT02417753
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites treatment 2 terminated NCT00006453
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy treatment 3 completed NCT06386653
Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1 No drug interventions diagnostic 1 enrolling_by_invitation NCT05518253
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04332653
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT06437353
Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer treatment 2 recruiting NCT03184753
Genetically Modified T Cells Against Ovarian Cancer No drug interventions treatment 1 / 2 unknown_status NCT01372553
Guilford Genomic Medicine Initiative (GGMI) No drug interventions Not Available Not Available completed NCT03604653
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers Not Available Not Available completed NCT00002977
Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission treatment 1 completed NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT04383977
Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer treatment 2 unknown_status NCT04295577
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR No drug interventions Not Available Not Available unknown_status NCT00002477
Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer treatment 3 unknown_status NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) No drug interventions supportive_care Not Available recruiting NCT05174377
CADx - Radiomics to Distinguish the Origin of Ovarian Tumors No drug interventions Not Available Not Available recruiting NCT00967577
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors treatment 1 completed NCT00170677
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer treatment 2 completed NCT03412877
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer treatment 2 recruiting NCT02110277
Photoacoustic Imaging of the Ovary No drug interventions diagnostic Not Available terminated NCT06562647
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors No drug interventions treatment Not Available recruiting NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT00022347
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT05001347
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors treatment 2 completed NCT06504147
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery No drug interventions prevention 2 recruiting NCT00103545
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response prevention 1 / 2 completed NCT00003345
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00078845
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors supportive_care 2 completed NCT05931445
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer No drug interventions treatment Not Available active_not_recruiting NCT03206645
Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy treatment 1 completed NCT05446545
Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT04701645
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer No drug interventions diagnostic 1 recruiting NCT00295945
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer Not Available Not Available completed NCT01432145
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours treatment 2 completed NCT03275298
Evolution of the Therapeutic Care in Ovarian Cancer From 2011 No drug interventions Not Available Not Available suspended NCT02672098
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer treatment 1 recruiting NCT04826198
Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months treatment 1 / 2 recruiting NCT04217798
Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer treatment 2 unknown_status NCT00855998
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT03127098
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer treatment 1 / 2 terminated NCT00442598
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer treatment 2 terminated NCT02393898
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older Not Available Not Available completed NCT05979298
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer treatment 2 active_not_recruiting NCT05446298
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer treatment 2 recruiting NCT03470805
Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma treatment 2 completed NCT00751205
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) treatment 2 completed NCT05030805
Transcriptional Map of Ovarian Cancer at the Single Cell Level No drug interventions Not Available Not Available recruiting NCT00582205
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma treatment 2 terminated NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT04710797
Lymphadenectomy in Early Ovarian Cancer No drug interventions treatment Not Available recruiting NCT02855697
Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer treatment 0 completed NCT00190697
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment treatment 4 completed NCT06457997
A Study of PHN-010 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02531997
A Mind-body Intervention to Improve Body and/or Self Image No drug interventions supportive_care Not Available completed NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT05857397
A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America No drug interventions Not Available Not Available recruiting NCT06392997
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology No drug interventions Not Available Not Available not_yet_recruiting NCT04414683
Factors Affecting the Prognosis of Early Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT06139783
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors No drug interventions prevention Not Available not_yet_recruiting NCT02222883
Prevalence of BRCA in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT01068483
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients treatment 1 completed NCT00004083
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer treatment 2 completed NCT05953883
PROTEOGENOMIC SIGNATURES ANALYSIS IN OVARIAN CANCER No drug interventions treatment Not Available recruiting NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome No drug interventions supportive_care Not Available terminated NCT05652283
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer treatment 2 active_not_recruiting NCT00045461
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 2 / 3 unknown_status NCT05964361
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients No drug interventions treatment 1 / 2 recruiting NCT00315861
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies treatment 1 completed NCT00019461
Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT03144661
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies No drug interventions treatment 1 terminated NCT00253461
11C Topotecan PET Imaging No drug interventions diagnostic 0 terminated NCT05761561
Trial of Exercise and Lifestyle in Women With Ovarian Cancer No drug interventions supportive_care Not Available recruiting NCT05255861
An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy No drug interventions Not Available Not Available recruiting NCT03933761
Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy treatment 2 withdrawn NCT01346761
Risk Education and Assessment for Cancer Heredity No drug interventions health_services_research Not Available completed NCT03959761
Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma treatment 1 / 2 unknown_status NCT00739661
A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission treatment 2 completed NCT02824328
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers No drug interventions Not Available Not Available completed NCT02321228
Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers No drug interventions prevention Not Available active_not_recruiting NCT01779128
PET-CT vs. Integrated MR-PET Scanning of GYN Cancers No drug interventions diagnostic 0 unknown_status NCT05410028
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence No drug interventions Not Available Not Available recruiting NCT00722228
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors No drug interventions prevention 1 / 2 unknown_status NCT05514028
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin No drug interventions Not Available Not Available recruiting NCT03772028
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) treatment 3 recruiting NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT00083928
Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels No drug interventions treatment 2 completed NCT04041128
PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer basic_science 0 completed NCT00006028
Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy treatment 2 completed NCT03539328
Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer treatment 2 unknown_status NCT02836028
A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer treatment 2 withdrawn NCT00653328
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma treatment 2 terminated NCT00002928
Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer treatment 2 completed NCT05225428
Video Education With Result Dependent dIsclosure No drug interventions health_services_research Not Available recruiting NCT00040911
Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma No drug interventions supportive_care Not Available completed NCT00382811
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer treatment 3 completed NCT05636111
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer treatment 1 recruiting NCT00003811
Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors treatment 2 completed NCT02340611
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib treatment 2 completed NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation supportive_care 1 / 2 completed NCT00976911
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer treatment 3 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT06290193
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery No drug interventions treatment 2 recruiting NCT02821793
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer No drug interventions Not Available Not Available unknown_status NCT03371693
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT02004093
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer treatment 2 completed NCT00096993
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT02269293
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers treatment 1 completed NCT00587093
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer No drug interventions diagnostic Not Available completed NCT02093871
A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer No drug interventions treatment 1 suspended NCT03889171
Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests No drug interventions Not Available Not Available completed NCT04823871
Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing No drug interventions diagnostic Not Available completed NCT03551171
The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer treatment 1 completed NCT04511871
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors No drug interventions treatment 1 recruiting NCT05255471
MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. treatment 3 recruiting NCT04180371
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression treatment 1 / 2 recruiting NCT05044871
Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer treatment 2 not_yet_recruiting NCT00098878
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT05025878
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. No drug interventions Not Available Not Available recruiting NCT00657878
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval treatment 3 active_not_recruiting NCT04941378
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer other 1 withdrawn NCT00574678
Analyzing the Composition of Tears to Identify Cancer No drug interventions diagnostic 1 / 2 completed NCT00002478
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer treatment 2 terminated NCT05445778
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) treatment 3 recruiting NCT00787488
Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca No drug interventions treatment Not Available withdrawn NCT02490488
Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients treatment 2 / 3 completed NCT03895788
A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer treatment 1 unknown_status NCT00033488
Screening Women at High Genetic Risk for Ovarian Cancer No drug interventions screening Not Available completed NCT02759588
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer No drug interventions treatment 1 / 2 completed NCT04511988
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal No drug interventions diagnostic Not Available active_not_recruiting NCT01953107
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. No drug interventions supportive_care 4 completed NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors treatment 1 completed NCT00023907
Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 2 terminated NCT03505307
Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation) No drug interventions Not Available Not Available completed NCT00607607
A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer treatment 2 completed NCT06383507
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT06118307
Shanghai Ovarian Cancer and Family Care Project No drug interventions Not Available Not Available recruiting NCT04492007
Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) No drug interventions supportive_care Not Available completed NCT04254107
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer treatment 1 terminated NCT06508307
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors treatment 1 recruiting NCT03393507
A Study of Apatinib Treatment in for Advanced Ovarian Cancer treatment 2 unknown_status NCT05048407
Sirius in Gynaecological Laparoscopic Surgery No drug interventions treatment Not Available recruiting NCT00437307
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse treatment 3 completed NCT00579007
Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations No drug interventions Not Available Not Available completed NCT05368207
Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient treatment Not Available active_not_recruiting NCT00433407
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors treatment Not Available completed NCT00173407
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion No drug interventions diagnostic Not Available withdrawn NCT06533709
Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data No drug interventions Not Available Not Available recruiting NCT05813509
Individualized Precision Treatment Based on Ovarian Cancer Organoid Model No drug interventions treatment Not Available recruiting NCT04512209
Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology No drug interventions basic_science Not Available recruiting NCT06024109
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy No drug interventions Not Available Not Available recruiting NCT00523809
Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor treatment 2 terminated NCT00004909
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer No drug interventions Not Available Not Available completed NCT04830709
Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT02407509
Phase I Trial of VS-6766 Alone and in Combination With Everolimus treatment 1 recruiting NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients No drug interventions diagnostic Not Available recruiting NCT01133756
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125 treatment 1 / 2 terminated NCT01686256
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer No drug interventions other 1 completed NCT01787656
A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus No drug interventions Not Available Not Available completed NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT00006356
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer treatment 3 terminated NCT03846856
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance No drug interventions Not Available Not Available unknown_status NCT05348356
Nirogacestat in Ovarian Granulosa Cell Tumors treatment 2 active_not_recruiting NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00326456
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer treatment 3 active_not_recruiting NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia No drug interventions Not Available Not Available completed NCT00346385
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT03345485
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT00039585
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor treatment 2 completed NCT00003385
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT04280185
HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC) No drug interventions treatment Not Available unknown_status NCT00002485
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer No drug interventions Not Available Not Available completed NCT02754115
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy No drug interventions Not Available Not Available recruiting NCT01584115
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) treatment 1 / 2 unknown_status NCT00002515
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer treatment 2 completed NCT03019315
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01432015
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting treatment 4 completed NCT01889615
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT02225015
Cancer Prevention in Women With a BRCA Mutation No drug interventions supportive_care 1 unknown_status NCT00581815
Spectroscopy With Surface Coils and Decoupling No drug interventions diagnostic 1 completed NCT00004115
Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy No drug interventions treatment 3 unknown_status NCT04229615
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy treatment 3 unknown_status NCT01083537
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction treatment 1 / 2 terminated NCT00004037
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer treatment 2 terminated NCT04122937
Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer. No drug interventions Not Available Not Available completed NCT00588237
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 2 completed NCT00758732
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma treatment 2 terminated NCT05472532
Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) No drug interventions other Not Available recruiting NCT02704832
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) No drug interventions other 3 unknown_status NCT00281632
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer treatment 2 completed NCT04337632
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer treatment 3 unknown_status NCT00058032
CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women No drug interventions screening Not Available completed NCT00711932
The Effect of TRA-8 on Ovarian Cancer Tissue No drug interventions Not Available Not Available completed NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT05976932
Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer Not Available Not Available not_yet_recruiting NCT03642132
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) treatment 3 terminated NCT00086632
Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment treatment 2 terminated NCT04244552
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies treatment 1 terminated NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors treatment 2 active_not_recruiting NCT04560452
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients No drug interventions Not Available Not Available recruiting NCT00585052
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer treatment 2 terminated NCT00757952
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction No drug interventions Not Available Not Available completed NCT04582552
The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer Not Available Not Available unknown_status NCT04188652
Diagnosing Ovarian Cysts - the DOC Study No drug interventions Not Available Not Available recruiting NCT00058552
A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer treatment 2 completed NCT00005952
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors treatment 1 / 2 completed NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies treatment 1 / 2 recruiting NCT05601752
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) treatment 2 recruiting NCT00003852
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors treatment 2 terminated NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT03759600
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer treatment 2 completed NCT02429700
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors treatment 3 recruiting NCT05506800
Guangzhou Women's Health Cohort Study (GWHCS) No drug interventions Not Available Not Available suspended NCT03549000
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. No drug interventions treatment 1 terminated NCT04032600
Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics No drug interventions supportive_care Not Available completed NCT01982500
Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT05523700
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) No drug interventions supportive_care Not Available recruiting NCT03644459
Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 No drug interventions treatment 1 withdrawn NCT00489359
Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer treatment 1 / 2 completed NCT01953159
Assessment of Paclitaxel-Induced Neuropathy No drug interventions Not Available Not Available active_not_recruiting NCT00829959
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) No drug interventions Not Available Not Available completed NCT02431559
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer treatment 1 / 2 completed NCT00429559
Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma treatment 1 / 2 completed NCT00036959
ABT-751 in Treating Young Patients With Refractory Solid Tumors treatment 1 completed NCT02792959
Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging No drug interventions diagnostic Not Available completed NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) No drug interventions treatment 1 recruiting NCT06253559
Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria No drug interventions Not Available Not Available completed NCT01821859
Abraxane/Bevacizumab treatment 2 terminated NCT04068675
Effects of Centering Pre-operative Counseling on Patient Reported Anxiety No drug interventions supportive_care Not Available completed NCT04691375
A Study of PY314 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT02610075
Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. treatment 1 completed NCT00288275
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer No drug interventions Not Available Not Available terminated NCT05394675
A Study of DS-9606a in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04742075
Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer treatment 2 recruiting NCT01104675
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer treatment 2 completed NCT01284075
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery No drug interventions supportive_care Not Available terminated NCT06324175
Spatial Radiogenomics of Ovarian Cancer: Implementation of a Lesion-specific 3D-printed Mould Pipeline in the Clinical Workflow for Image-guided Tissue Multi-sampling of Ovarian Tumours No drug interventions Not Available Not Available recruiting NCT01767675
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 active_not_recruiting NCT02916875
Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision Making No drug interventions Not Available Not Available completed NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT02914470
Carboplatin-cyclophosphamide Combined With Atezolizumab treatment 1 completed NCT02151370
An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00318370
Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy treatment 2 completed NCT05467670
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer treatment 2 recruiting NCT04768270
The Culture of Ovarian Cancer Organoids and Drug Screening No drug interventions Not Available Not Available recruiting NCT03936270
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer treatment 2 completed NCT06063070
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer treatment 2 not_yet_recruiting NCT05804370
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) diagnostic 3 recruiting NCT06040970
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer treatment 1 / 2 not_yet_recruiting NCT01167842
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer) No drug interventions Not Available Not Available completed NCT00660842
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer treatment 3 active_not_recruiting NCT00117442
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood treatment 2 completed NCT05918042
A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation No drug interventions Not Available Not Available recruiting NCT05204342
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France No drug interventions Not Available Not Available completed NCT04931342
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors treatment 2 active_not_recruiting NCT01144442
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer treatment Not Available terminated NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S No drug interventions treatment 1 completed NCT03219242
Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology No drug interventions basic_science Not Available unknown_status NCT00434642
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma treatment 3 completed NCT06553742
High Definition Profiling of Ovarian Cancer Ascites No drug interventions Not Available Not Available not_yet_recruiting NCT00738699
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer treatment 2 terminated NCT04408599
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT04300699
Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer No drug interventions supportive_care Not Available unknown_status NCT00854399
Screening and Identification of Ovarian Cancers No drug interventions basic_science Not Available unknown_status NCT06305299
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells treatment 1 recruiting NCT02470299
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients basic_science Not Available active_not_recruiting NCT05583799
Efficacy and Adverse Effects of Niraparib in Ovarian Cancer. No drug interventions Not Available Not Available not_yet_recruiting NCT00023699
Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 2 completed NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01387399
Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer No drug interventions treatment 1 unknown_status NCT00533299
Hydralazine Valproate for Ovarian Cancer treatment 3 unknown_status NCT01187706
A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors No drug interventions Not Available Not Available unknown_status NCT00004206
Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer treatment 2 unknown_status NCT00496106
Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes No drug interventions health_services_research Not Available completed NCT01610206
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer treatment 2 completed NCT00578006
Internet-based System for Cancer Patients to Self-report Toxicity No drug interventions Not Available Not Available completed NCT00601406
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer No drug interventions treatment Not Available unknown_status NCT05430906
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer treatment 2 recruiting NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00897806
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer No drug interventions Not Available Not Available terminated NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies No drug interventions treatment 1 / 2 unknown_status NCT04489706
Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation treatment Not Available unknown_status NCT05641506
A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer treatment 2 not_yet_recruiting NCT03362606
Engineered Immune Effectors Against Ovarian Cancer No drug interventions treatment 1 / 2 unknown_status NCT00030706
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 completed NCT03171506
Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification No drug interventions treatment Not Available completed NCT04699006
Efficacy and Adverse Effects of Olaparib in Ovarian Cancer. No drug interventions Not Available Not Available enrolling_by_invitation NCT06307249
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA treatment 1 recruiting NCT03783949
European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer treatment 2 completed NCT00005049
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer treatment 2 completed NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT01623349
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer treatment 1 completed NCT02928549
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study No drug interventions Not Available Not Available completed NCT01204749
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer treatment 3 completed NCT00563836
Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer treatment 2 completed NCT00003136
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer treatment 1 / 2 completed NCT00770536
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR treatment 1 completed NCT05633836
MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer No drug interventions diagnostic Not Available recruiting NCT00831636
A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer treatment 1 / 2 completed NCT03509636
A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer treatment 1 completed NCT00006036
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors treatment 1 completed NCT06037213
A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib No drug interventions Not Available Not Available recruiting NCT02125513
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer treatment 2 active_not_recruiting NCT00007813
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors treatment 1 completed NCT00520013
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors treatment 2 completed NCT04927013
Connecting Families to Overcome Ovarian Cancer No drug interventions health_services_research Not Available completed NCT01216813
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer No drug interventions Not Available Not Available completed NCT05057013
HMBD-001 in Advanced HER3 Positive Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT03742713
Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer treatment 2 completed NCT00059618
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer treatment 1 completed NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. No drug interventions treatment 1 active_not_recruiting NCT02828618
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer No drug interventions treatment Not Available active_not_recruiting NCT05069818
Variance of HRD From Paired Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT06440018
INSPIRE: A Multi-Cancer Early Detection Study No drug interventions Not Available Not Available not_yet_recruiting NCT06320418
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression No drug interventions Not Available Not Available active_not_recruiting NCT00276718
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors treatment Not Available unknown_status NCT02684318
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors treatment 1 / 2 unknown_status NCT02560818
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer No drug interventions diagnostic Not Available completed NCT00744718
Bevacizumab and Carboplatin for Patients With Ovarian Cancer treatment 2 completed NCT01570218
Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy No drug interventions supportive_care Not Available completed NCT02341118
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome. No drug interventions Not Available Not Available terminated NCT02539719
Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer treatment 1 terminated NCT00228319
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants treatment 1 / 2 completed NCT03023319
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors treatment 1 completed NCT00019019
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas treatment 1 completed NCT04038619
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients treatment 1 recruiting NCT00002819
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer treatment 3 terminated NCT03028519
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer treatment 0 completed NCT03738319
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT06558019
Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence No drug interventions Not Available Not Available not_yet_recruiting NCT00507741
Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) treatment 2 completed NCT04731441
Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact No drug interventions treatment Not Available terminated NCT01556841
The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer treatment 2 completed NCT00683241
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT02856841
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer No drug interventions Not Available Not Available completed NCT00516841
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer treatment 2 terminated NCT06430541
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence supportive_care 1 recruiting NCT00667641
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors treatment 1 completed NCT05905341
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. treatment 1 withdrawn NCT04507841
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer treatment 2 completed NCT00006041
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer No drug interventions treatment 1 completed NCT01196741
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer treatment 2 / 3 completed NCT01272817
Nonmyeloablative Allogeneic Transplant No drug interventions treatment Not Available completed NCT00479817
Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT00886717
Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer treatment 1 / 2 unknown_status NCT04602117
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer treatment 1 withdrawn NCT06182917
Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients No drug interventions Not Available Not Available recruiting NCT02117817
Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer treatment 1 withdrawn NCT05496517
Ovarian Cancer Individualized Scoring System Scoring System No drug interventions Not Available Not Available unknown_status NCT03342417
Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients treatment 2 terminated NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT00017017
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 / 2 completed NCT00373217
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 2 terminated NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma treatment 1 recruiting NCT03540017
HIPEC After Initial CRS in Patients Who Have Received NACT treatment 1 recruiting NCT02718417
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) treatment 3 terminated NCT04747717
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer No drug interventions treatment Not Available recruiting NCT06342934
Radiomics and Machine Learning in the Diagnosis of Ovarian Masses No drug interventions Not Available Not Available completed NCT00027534
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer No drug interventions treatment 1 completed NCT00317434
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer treatment 1 terminated NCT00017134
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk prevention Not Available terminated NCT00003634
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy treatment 2 unknown_status NCT00004934
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 3 completed NCT05564234
Role of Laparoscopy in Assessing Resectability of Ovarian Cancer No drug interventions treatment Not Available completed NCT00003624
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer supportive_care 2 terminated NCT01433224
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression No drug interventions Not Available Not Available completed NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant supportive_care 3 terminated NCT05640024
Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors No drug interventions Not Available Not Available recruiting NCT02891824
ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab treatment 3 active_not_recruiting NCT02452424
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors treatment 1 / 2 terminated NCT02418624
Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer treatment 1 completed NCT01972516
Tivozanib As Maintenance Therapy In GYN treatment 2 terminated NCT04828616
Study of DP303c Injection in Patients With Advanced Ovarian Cancer treatment 2 unknown_status NCT04330716
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers No drug interventions health_services_research Not Available completed NCT02015416
A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer treatment 1 completed NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers treatment 1 terminated NCT00296816
TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary treatment 2 completed NCT00740116
Tranexamic Acid in Surgery of Advanced Ovarian Cancer treatment 4 completed NCT04661696
Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. treatment 2 unknown_status NCT05259696
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) treatment 1 / 2 active_not_recruiting NCT00070096
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors treatment 2 completed NCT00020696
Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 completed NCT01580696
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer treatment 1 / 2 completed NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy No drug interventions treatment 1 / 2 completed NCT00003358
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT02580058
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) treatment 3 completed NCT00905658
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer No drug interventions supportive_care 2 unknown_status NCT00164658
Evaluating Tools for Health Promotion and Disease Prevention No drug interventions prevention 1 completed NCT06065358
Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction No drug interventions treatment Not Available recruiting NCT06552858
Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer treatment 2 not_yet_recruiting NCT01606358
Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer Not Available Not Available withdrawn NCT00407758
Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 2 completed NCT02349958
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy No drug interventions treatment 2 unknown_status NCT00002558
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors treatment 1 / 2 completed NCT00005858
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer No drug interventions treatment 1 completed NCT03921658
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer No drug interventions Not Available Not Available completed NCT00804258
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT06018935
A Cohort Establishment Study of Total Management of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03314935
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors treatment 1 / 2 completed NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours No drug interventions treatment 1 recruiting NCT04122235
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study No drug interventions supportive_care Not Available recruiting NCT01770535
Oxford Ovarian Cancer Predict Chemotherapy Response 01 No drug interventions Not Available Not Available unknown_status NCT01223235
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab treatment Not Available completed NCT00194935
Weekly Topotecan Therapy in Patients With Ovarian Cancer treatment 2 terminated NCT00726635
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies No drug interventions supportive_care 3 unknown_status NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj. No drug interventions Not Available Not Available unknown_status NCT01041235
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies treatment 1 completed NCT06572735
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT02092363
Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer treatment 1 completed NCT04533763
Living WELL: A Web-Based Program for Ovarian Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT04154163
Appropriate Dosing to Optimise Personalised Cancer Treatments No drug interventions Not Available Not Available completed NCT03146663
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer treatment 2 terminated NCT01936363
Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer treatment 2 completed NCT04847063
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies diagnostic 1 recruiting NCT00003763
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer No drug interventions diagnostic Not Available completed NCT01905163
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients No drug interventions treatment 2 completed NCT04421963
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib treatment 3 enrolling_by_invitation NCT06574763
Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer treatment 2 not_yet_recruiting NCT06531486
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 not_yet_recruiting NCT00466986
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer treatment 2 completed NCT06250686
Exercise and Nutrition Intervention in Ovarian Cancer No drug interventions supportive_care Not Available recruiting NCT06342986
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 recruiting NCT00461786
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT00750386
Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas treatment 1 / 2 completed NCT02970786
Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans No drug interventions diagnostic 1 unknown_status NCT00477386
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer treatment 1 / 2 completed NCT00003386
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer treatment 2 terminated NCT01097239
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer No drug interventions supportive_care 1 / 2 withdrawn NCT01747239
Cabazitaxel in Platinum Refractory Ovarian Cancer treatment 2 terminated NCT03755739
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors treatment 2 / 3 recruiting NCT04520139
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT No drug interventions treatment 1 / 2 not_yet_recruiting NCT03532139
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) prevention 2 active_not_recruiting NCT00096239
CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 2 completed NCT03558139
Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy treatment 1 completed NCT04473339
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation No drug interventions treatment 3 unknown_status NCT00003939
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma treatment 2 completed NCT00897039
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer No drug interventions Not Available Not Available unknown_status NCT01588522
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease prevention 1 completed NCT06304922
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary No drug interventions Not Available Not Available not_yet_recruiting NCT06229522
Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA). No drug interventions Not Available Not Available recruiting NCT01583322
Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer treatment 2 completed NCT02593422
Writing About Experiences With Ovarian Cancer No drug interventions supportive_care Not Available completed NCT01766622
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant No drug interventions diagnostic 2 withdrawn NCT00102622
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer treatment 1 terminated NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT02728622
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane treatment 3 completed NCT05051722
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer No drug interventions Not Available Not Available recruiting NCT00551122
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors treatment 1 / 2 unknown_status NCT02978222
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer treatment 2 terminated NCT04227522
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients treatment 3 active_not_recruiting NCT06232122
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer No drug interventions diagnostic Not Available recruiting NCT00669422
ChemoFx® PRO - A Post-Market Data Collection Study No drug interventions Not Available Not Available terminated NCT02534922
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer treatment 1 unknown_status NCT00132522
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide No drug interventions treatment 1 completed NCT00583622
Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients treatment 2 terminated NCT00263822
Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer treatment 3 completed NCT00003425
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect treatment 1 / 2 completed NCT00179725
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma treatment 1 / 2 terminated NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors treatment 1 completed NCT05318625
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. No drug interventions treatment Not Available enrolling_by_invitation NCT05082025
Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations treatment 2 active_not_recruiting NCT04590625
Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer treatment 2 unknown_status NCT05960630
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT00903630
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT05922930
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer treatment 1 / 2 recruiting NCT05053230
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer No drug interventions supportive_care Not Available recruiting NCT04681248
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors Not Available Not Available available NCT02632448
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer basic_science 1 / 2 recruiting NCT01601548
Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy No drug interventions supportive_care Not Available completed NCT02884648
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery treatment 2 recruiting NCT00400348
Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer treatment 2 completed NCT00595348
Korean Hereditary Breast Cancer Study No drug interventions Not Available Not Available unknown_status NCT01223248
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy No drug interventions treatment 3 active_not_recruiting NCT03235648
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT06436248
Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00006357
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma treatment 1 / 2 completed NCT00426257
Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer No drug interventions treatment 3 completed NCT00101257
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT05041257
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) treatment 2 active_not_recruiting NCT04461457
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2 No drug interventions treatment 0 completed NCT05829057
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 No drug interventions treatment 1 recruiting NCT00004157
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors treatment 2 completed NCT00005026
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer treatment 1 completed NCT03797326
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) treatment 2 active_not_recruiting NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02433626
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies treatment 1 unknown_status NCT04590326
A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 treatment 1 / 2 recruiting NCT05175326
Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs No drug interventions Not Available Not Available unknown_status NCT03719326
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies treatment 1 completed NCT05721326
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition No drug interventions health_services_research Not Available enrolling_by_invitation NCT00964626
Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer treatment 2 unknown_status NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT03804866
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018) treatment 2 completed NCT00004066
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma treatment 2 completed NCT00114166
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy treatment 3 completed NCT06473766
Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses No drug interventions diagnostic Not Available not_yet_recruiting NCT00470366
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors treatment 2 completed NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer treatment 1 completed NCT02411565
Fermented Wheat Germ Extract in Women With Ovarian Cancer No drug interventions treatment 0 terminated NCT02576665
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) treatment 1 terminated NCT02562365
Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer treatment 2 unknown_status NCT02498665
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies treatment 1 completed NCT00003865
Toremifene in Treating Patients With Ovarian Cancer treatment 2 withdrawn NCT03519165
Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery No drug interventions treatment Not Available completed NCT04823065
4FMFES-PET Imaging of Endometrial and Ovarian Cancers diagnostic 1 / 2 completed NCT03538665
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons No drug interventions Not Available Not Available recruiting NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT05693974
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study) No drug interventions Not Available Not Available active_not_recruiting NCT03246074
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer treatment 1 active_not_recruiting NCT05504174
Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay. No drug interventions Not Available Not Available completed NCT00436774
Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01 No drug interventions Not Available Not Available unknown_status NCT05914974
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies No drug interventions Not Available Not Available recruiting NCT03298074
Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT06412120
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib treatment 4 not_yet_recruiting NCT01706120
Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab treatment 4 active_not_recruiting NCT04675320
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors No drug interventions Not Available Not Available active_not_recruiting NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT04214782
Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging Algorithm No drug interventions diagnostic Not Available not_yet_recruiting NCT03818282
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer treatment 2 not_yet_recruiting NCT02766582
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer treatment 2 completed NCT05431582
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors treatment 1 withdrawn NCT00889382
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) treatment 1 / 2 completed NCT05009082
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer treatment 3 recruiting NCT00477282
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer treatment 3 completed NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT00004082
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors treatment 1 completed NCT00483782
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 3 completed NCT00842582
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer treatment 1 withdrawn NCT00854282
The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression No drug interventions basic_science Not Available unknown_status NCT00287482
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. No drug interventions treatment Not Available terminated NCT06152731
HRD Tests for Ovarian cancER No drug interventions diagnostic 2 recruiting NCT04714931
Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5) No drug interventions diagnostic Not Available unknown_status NCT00982631
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer treatment 1 unknown_status NCT02963831
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies treatment 1 / 2 completed NCT03992131
A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) treatment 1 / 2 terminated NCT00002931
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer treatment 2 completed NCT04284631
Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma. No drug interventions Not Available Not Available completed NCT02354131
Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer treatment 1 / 2 completed NCT03622931
Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines treatment 2 terminated NCT00291473
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers treatment 1 completed NCT00569673
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer treatment 2 completed NCT00170573
Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer treatment 2 completed NCT00003773
IM-862 in Treating Patients With Recurrent Ovarian Cancer treatment 1 completed NCT01248273
Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission treatment 1 completed NCT05458973
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation. No drug interventions Not Available Not Available recruiting NCT00765973
Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors treatment 1 completed NCT00381173
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing treatment 1 completed NCT00626873
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary diagnostic 1 completed NCT05574673
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype No drug interventions Not Available Not Available recruiting NCT02933073
Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma No drug interventions treatment 1 terminated NCT03017573
Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) No drug interventions basic_science Not Available recruiting NCT00157573
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer treatment 2 completed NCT00748527
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 terminated NCT04739527
Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment treatment 1 active_not_recruiting NCT05812027
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors No drug interventions Not Available Not Available recruiting NCT00419627
Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas No drug interventions Not Available Not Available unknown_status NCT02374827
Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE) No drug interventions treatment Not Available completed NCT04298827
Gyn Onc Prehab Study No drug interventions supportive_care Not Available completed NCT00237627
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer treatment 1 / 2 completed NCT05349227
Comprehensive Outcomes for After Cancer Health No drug interventions supportive_care Not Available recruiting NCT06339827
ASk Questions in GYnecologic Oncology (ASQ-GYO) No drug interventions health_services_research Not Available recruiting NCT05316376
Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial treatment 2 not_yet_recruiting NCT01188876
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer treatment 1 / 2 completed NCT02288676
DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics No drug interventions Not Available Not Available recruiting NCT04696276
Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece No drug interventions health_services_research Not Available unknown_status NCT04770376
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab No drug interventions Not Available Not Available recruiting NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas treatment 2 active_not_recruiting NCT00716976
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy supportive_care 3 completed NCT02221076
Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. No drug interventions diagnostic Not Available completed NCT00004876
Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer treatment 2 completed NCT03891576
Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer) treatment 2 active_not_recruiting NCT03205176
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas treatment 1 completed NCT03863860
A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients treatment 3 unknown_status NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT00157560
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma No drug interventions treatment 2 completed NCT00277160
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer prevention 4 completed NCT00603460
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer other 1 / 2 withdrawn NCT06380660
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT00003160
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum treatment 2 unknown_status NCT00002960
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) treatment 1 completed NCT04163094
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy No drug interventions treatment 1 terminated NCT02960594
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse prevention 1 completed NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types treatment 1 / 2 recruiting NCT00900094
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer No drug interventions Not Available Not Available completed NCT03128294
Long Term Survivors in Ovarian Cancer No drug interventions Not Available Not Available terminated NCT00634894
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 withdrawn NCT04789694
Prehabilitation in Gynaecological Cancer Patients No drug interventions supportive_care 3 recruiting NCT04507191
PDL1 in Ovarian High Grade Serous Carcinoma No drug interventions Not Available Not Available completed NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors No drug interventions supportive_care Not Available completed NCT00006391
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT06276491
Phase 1, Safety and Tolerability Study of XmAb®541 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06328491
Erdafitinib in Metastatic Steroid-cell Ovarian Cancer treatment Not Available completed NCT00856791
Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients treatment 2 completed NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program No drug interventions supportive_care Not Available completed NCT00032162
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer treatment 1 / 2 completed NCT03543462
Diaphragmatic Resection And Gynecological Ovarian Neoplasm No drug interventions treatment 4 completed NCT01248962
Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 completed NCT03393962
Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors No drug interventions treatment 1 / 2 suspended NCT05021562
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice Not Available Not Available recruiting NCT05401162
Chemotherapy Supported by Autologous Hematopoietic Stem Cells No drug interventions treatment Not Available recruiting NCT05272462
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer treatment 2 recruiting NCT00003080
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer treatment 1 completed NCT06490380
HRD Status Reference Standard Based on WGS No drug interventions Not Available Not Available completed NCT05735080
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT05568680
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma treatment 1 recruiting NCT00003380
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 1 terminated NCT03164980
Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer treatment 4 completed NCT00593580
Bone Health in Gynecologic Cancers-does FOSAVANCE Help? prevention 2 completed NCT05646680
A Performance Study of (Opportunistic) Salpingectomy No drug interventions treatment Not Available recruiting NCT00856180
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies treatment 2 completed NCT00753480
A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer No drug interventions treatment 1 suspended NCT05494580
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer treatment 1 / 2 recruiting NCT05316129
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer treatment 1 recruiting NCT05840029
VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES No drug interventions Not Available Not Available active_not_recruiting NCT05842629
Improved Diagnosis of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03648489
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) treatment 2 unknown_status NCT00002489
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors treatment 2 completed NCT03614689
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire No drug interventions Not Available Not Available active_not_recruiting NCT06171789
PRO1107 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT02725489
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers treatment 2 completed NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer treatment 1 / 2 completed NCT03225989
Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer treatment 1 / 2 active_not_recruiting NCT04089189
Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer treatment 2 unknown_status NCT03635489
A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT00113789
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer No drug interventions treatment 2 completed NCT04787289
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer treatment 2 recruiting NCT00421889
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment treatment 1 / 2 completed NCT00722592
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) treatment 2 completed NCT05606692
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics) treatment 4 recruiting NCT00003892
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer No drug interventions treatment 2 completed NCT00315692
Risk of Ovarian Cancer in Patients With a Pelvic Mass No drug interventions Not Available Not Available completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05372692
Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer No drug interventions treatment Not Available completed NCT03150992
EDMONd - Elemental Diet in Bowel Obstruction No drug interventions supportive_care Not Available unknown_status NCT04417192
Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer treatment 2 completed NCT00610792
Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens treatment 2 withdrawn NCT02465892
Pillars4Life Trial No drug interventions supportive_care Not Available completed NCT00501644
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer treatment 2 completed NCT03399344
Clinical Impact of Dedicated MR Staging of Ovarian Cancer No drug interventions diagnostic Not Available unknown_status NCT02477644
Platine, Avastin and OLAparib in 1st Line treatment 3 completed NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02537444
Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191) treatment 2 completed NCT02326844
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment treatment 2 terminated NCT02855944
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients treatment 3 completed NCT06395844
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer No drug interventions treatment 1 / 2 recruiting NCT06083844
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy treatment 2 recruiting NCT00303940
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors treatment 1 completed NCT05032040
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies treatment 2 recruiting NCT05862740
ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT03958240
Deciphering Mechanisms Underlying Cancer Immunogenicity No drug interventions other Not Available recruiting NCT00879840
Assessment of Screening Modalities for Gynecologic Cancers No drug interventions Not Available Not Available completed NCT00155740
Mesothelin as a New Tumor Marker for Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT04339140
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer treatment 2 recruiting NCT00946140
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study No drug interventions Not Available Not Available completed NCT03382340
IMX-110 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT00753740
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients. treatment 2 withdrawn NCT04330040
Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer treatment 4 completed NCT03363867
BEACON - ABC in Recurrent Platinum Resistant HGSOC treatment 2 active_not_recruiting NCT04464967
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers treatment 1 / 2 withdrawn NCT04367467
Effect of PARP Inhibitors on Glomerular Filtration Rate No drug interventions Not Available Not Available terminated NCT00408967
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. treatment 2 withdrawn NCT02312167
Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) No drug interventions treatment Not Available completed NCT01175967
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer No drug interventions Not Available Not Available terminated NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT02109367
Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass No drug interventions Not Available Not Available active_not_recruiting NCT03704467
Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer treatment 1 completed NCT05274867
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment No drug interventions Not Available Not Available unknown_status NCT06048367
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor treatment 1 recruiting NCT04731467
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05810701
FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer No drug interventions treatment Not Available recruiting NCT04817501
Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System No drug interventions Not Available Not Available completed NCT05697601
Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools No drug interventions Not Available Not Available recruiting NCT00825201
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity treatment 1 completed NCT02458001
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer No drug interventions treatment Not Available unknown_status NCT05610501
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. No drug interventions Not Available Not Available recruiting NCT05201001
APX005M in Patients With Recurrent Ovarian Cancer treatment 2 withdrawn NCT01180504
Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer No drug interventions treatment 2 unknown_status NCT06085404
Patients Derived Organoids in Ovarian Cancer No drug interventions treatment Not Available recruiting NCT02483104
Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer treatment 1 completed NCT01937104
ONSD According to the Position During Laparoscopy diagnostic Not Available completed NCT03931304
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) No drug interventions Not Available Not Available completed NCT06545604
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT05523804
Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors No drug interventions Not Available Not Available completed NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT01100372
Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 2 unknown_status NCT03159572
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations No drug interventions Not Available Not Available completed NCT06403072
(GI-RADS) in Preoperative Evaluation of Adnexal Masses No drug interventions Not Available Not Available completed NCT00317772
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 completed NCT02001272
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer treatment 2 completed NCT06161272
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi treatment 2 not_yet_recruiting NCT05912972
Development and Management of Registry in Patients With Gynecologic Cancer in Korea No drug interventions Not Available Not Available recruiting NCT05649072
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. No drug interventions screening Not Available recruiting NCT00003072
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer supportive_care 2 completed NCT03069872
A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer No drug interventions diagnostic Not Available completed NCT04657068
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT05132868
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling No drug interventions supportive_care Not Available completed NCT03732768
Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis No drug interventions prevention 1 active_not_recruiting NCT00217568
Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer treatment 2 completed NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCT No drug interventions Not Available Not Available terminated NCT05669768
Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy treatment 2 not_yet_recruiting NCT05797168
Phase I/IIa Study for AZD5335 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors treatment 1 / 2 recruiting NCT00539968
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) treatment 1 / 2 terminated NCT00052468
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer treatment 3 completed NCT05113368
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer treatment 2 recruiting NCT00002568
Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer treatment 3 completed NCT04451369
Connected Prehabilitation Program During Neo Adjuvant Chemotherapy No drug interventions supportive_care Not Available not_yet_recruiting NCT00003569
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel Not Available Not Available completed NCT01834469
Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients No drug interventions diagnostic 1 / 2 completed NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors No drug interventions treatment 1 recruiting NCT00003269
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors supportive_care 2 completed NCT03490669
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors No drug interventions treatment 1 completed NCT00819169
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors treatment 1 / 2 terminated NCT04284969
PROADAPT-ovary/EWOC-2 No drug interventions supportive_care Not Available recruiting NCT01610869
Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer treatment 2 completed NCT05145569
Antitumor Activity of Neoadjuvant Chemotherapy With or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer treatment 2 recruiting NCT04354246
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies treatment 1 recruiting NCT00005046
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer treatment 1 completed NCT00030446
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors treatment 0 recruiting NCT03639246
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer treatment 1 completed NCT04398446
Effect of Hemp-CBD on Patients With CIPN treatment 2 unknown_status NCT01040312
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Not Available Not Available completed NCT06385912
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer No drug interventions Not Available Not Available completed NCT00075712
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 / 3 completed NCT00179712
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma Not Available 1 / 2 completed NCT00082212
A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma treatment 2 terminated NCT00006812
Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer treatment 2 terminated NCT00005612
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer treatment 1 / 2 terminated NCT03863912
Impact of Disney Movies During Chemotherapy on QOL of Gynecologic Oncology Patients No drug interventions supportive_care Not Available completed NCT00436410
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer treatment 0 completed NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors treatment 2 active_not_recruiting NCT00428610
A Study of Chemotherapy Treatment for Patients With Ovarian Cancer treatment 2 completed NCT01991210
A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) treatment 2 terminated NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Not Available Not Available available NCT00453310
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment treatment 2 completed NCT05645510
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study No drug interventions Not Available Not Available recruiting NCT02545010
Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer treatment 1 unknown_status NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease No drug interventions Not Available Not Available recruiting NCT00004081
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 completed NCT03281681
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer treatment 1 / 2 withdrawn NCT01253681
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer treatment 1 completed NCT05585281
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy treatment 2 recruiting NCT00420381
Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT05256381
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors treatment 2 active_not_recruiting NCT03154281
Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast treatment 1 completed NCT00006981
Immunotoxin Therapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00898781
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT00664781
Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer treatment 2 completed NCT00004895
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery supportive_care 2 completed NCT06390995
A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors treatment 1 / 2 recruiting NCT00620295
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors treatment 1 completed NCT00005095
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention No drug interventions Not Available Not Available recruiting NCT00672295
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer treatment 1 completed NCT03446495
An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer Not Available Not Available unknown_status NCT00003795
Quality of Life in Survivors of Gynecologic Cancer No drug interventions Not Available Not Available completed NCT04911114
Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT00787514
FR in Stored Plasma No drug interventions Not Available Not Available completed NCT00579514
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients No drug interventions screening Not Available active_not_recruiting NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications treatment 1 recruiting NCT00055614
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT06541314
Fluzoparib Neoadjuvant Therapy for Ovarian Cancer treatment 2 recruiting NCT01132014
Autologous OC-DC Vaccine in Ovarian Cancer No drug interventions treatment 0 completed NCT03032614
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients treatment 2 withdrawn NCT04606914
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 recruiting NCT05776355
NKG2D CAR-NK & Ovarian Cancer No drug interventions treatment Not Available recruiting NCT02346955
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) treatment 1 terminated NCT01954355
LDE225 and Paclitaxel in Solid Tumors treatment 1 completed NCT00217555
Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 completed NCT01685255
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy treatment 2 terminated NCT00006155
SU5416 and Carboplatin to Treat Ovarian Cancer treatment 1 completed NCT06215950
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer No drug interventions treatment 1 recruiting NCT05974150
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring No drug interventions Not Available Not Available recruiting NCT04454450
Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT01170650
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) treatment 3 terminated NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) treatment 1 / 2 recruiting NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) treatment 1 / 2 recruiting NCT00003450
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT02457650
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies treatment 1 unknown_status NCT00866723
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer treatment 2 terminated NCT06211023
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer treatment 2 / 3 not_yet_recruiting NCT00900523
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00005023
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer treatment 1 completed NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis No drug interventions Not Available Not Available recruiting NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer treatment 2 completed NCT00002508
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors treatment 1 / 2 completed NCT00003308
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma No drug interventions treatment 2 completed NCT03189108
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors No drug interventions Not Available Not Available completed NCT04812938
Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test No drug interventions Not Available Not Available unknown_status NCT03763838
Acupressure for Fatigue in Ovarian Cancer Survivors No drug interventions supportive_care Not Available completed NCT00008138
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer treatment 2 completed NCT03507543
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors treatment 1 completed NCT03657043
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) treatment 2 completed NCT00075543
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer treatment 1 / 2 unknown_status NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT03917043
APG-2449 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00002943
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer treatment 2 completed NCT02133703
Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility No drug interventions supportive_care Not Available completed NCT04542603
Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer No drug interventions diagnostic 1 withdrawn NCT05708703
Assessing the Time Demands of Cancer No drug interventions Not Available Not Available recruiting NCT05529303
Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients No drug interventions supportive_care Not Available completed NCT01778803
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer treatment 1 completed NCT00002903
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer treatment 2 completed NCT02432690
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation treatment 2 terminated NCT00005590
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma supportive_care 3 completed NCT02055690
PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT02121990
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 1 completed NCT05206890
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer Not Available Not Available recruiting NCT06014190
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer No drug interventions treatment 2 recruiting NCT00459290
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT04237090
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel prevention 3 completed NCT00170690
Preference Study With Elderly Patients Recurrent Ovarian Cancer treatment 3 completed NCT00408590
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 1 completed NCT05468190
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T No drug interventions treatment 1 recruiting NCT02326064
Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4 No drug interventions Not Available Not Available completed NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors treatment 1 recruiting NCT00002764
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma treatment 3 completed NCT01388621
Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT05065021
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor treatment 2 recruiting NCT05704621
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance No drug interventions treatment 2 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02714621
MR-HIFU for Recurrent Gynaecological Cancer No drug interventions treatment Not Available completed NCT00227721
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer treatment 2 completed NCT06445621
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test No drug interventions Not Available Not Available recruiting NCT04051502
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study Not Available Not Available active_not_recruiting NCT02218502
Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses No drug interventions diagnostic Not Available terminated NCT01187602
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT00001302
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 treatment 1 completed NCT02638402
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers No drug interventions Not Available Not Available unknown_status NCT04392102
A Study of Niraparib in Patients With Relapsed Ovarian Cancer treatment 2 completed NCT05738902
Adherence and Compliance to ERAS in Gynecological Surgery No drug interventions Not Available Not Available recruiting NCT03470402
Decision Support for BRCA Testing in Ethnically Diverse Women No drug interventions prevention Not Available completed NCT00003002
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer treatment 1 completed NCT03042702
A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer treatment 2 completed NCT00488202
Advanced Ovarian Cancer and Sexuality Phase 1 No drug interventions Not Available Not Available completed NCT03197584
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy treatment 1 / 2 withdrawn NCT00531284
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma treatment 1 / 2 completed NCT05572684
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04176484
Feasibility of Opportunistic Salpingectomy During Non-Gynecologic Surgery No drug interventions Not Available Not Available unknown_status NCT06238284
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China No drug interventions Not Available Not Available not_yet_recruiting NCT02713984
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer No drug interventions treatment 1 / 2 withdrawn NCT03410784
Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer treatment 2 recruiting NCT05364879
Prehabilitation for Ovarian Cancer Patients No drug interventions supportive_care Not Available recruiting NCT00900679
Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT05866679
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging No drug interventions diagnostic 1 recruiting NCT00010179
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer treatment 2 completed NCT00817479
Tumor Gene Expression in Women With Ovarian Cancer basic_science 4 completed NCT00383279
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer No drug interventions other Not Available completed NCT01247779
Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy No drug interventions treatment Not Available completed NCT03916679
MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer treatment 1 / 2 unknown_status NCT02351479
Hula, a Physical Activity Intervention for Female-Cancer Survivors No drug interventions supportive_care Not Available completed NCT02737787
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer treatment 1 completed NCT03079687
Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer. Not Available Not Available approved_for_marketing NCT04377087
Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer treatment 2 terminated NCT02785887
Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients No drug interventions health_services_research Not Available completed NCT05693987
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study) No drug interventions Not Available Not Available recruiting NCT01212887
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer treatment 1 terminated NCT05427487
Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours treatment 1 recruiting NCT04729387
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected treatment 3 active_not_recruiting NCT00087087
Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 2 completed NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy treatment 1 / 2 active_not_recruiting NCT00053833
S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 terminated NCT04805333
Phase 1 Dose Escalation of ArtemiCoffee No drug interventions treatment 1 active_not_recruiting NCT02764333
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer treatment 2 completed NCT04473833
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer No drug interventions screening Not Available recruiting NCT05483933
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers treatment 1 active_not_recruiting NCT03762733
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies No drug interventions Not Available Not Available enrolling_by_invitation NCT00003733
Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer treatment 2 unknown_status NCT04024254
A Study of Serum Folate Levels in Patients Treated With Olaparib treatment 2 / 3 active_not_recruiting NCT00006454
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer treatment 3 completed NCT05029154
Exercise Preconditioning in Ovarian Cancer No drug interventions prevention Not Available recruiting NCT00813254
Cost Utility Analysis in Recurrent Ovarian Cancer No drug interventions Not Available Not Available withdrawn NCT00628654
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants No drug interventions Not Available Not Available completed NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT00031954
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00005051
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer treatment 2 completed NCT01704651
Accelerating Gastrointestinal Recovery prevention 3 completed NCT02054351
Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) treatment 1 completed NCT00574951
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 terminated NCT02033551
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors treatment 1 completed NCT03454451
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers treatment 1 completed NCT00034151
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer treatment 2 completed NCT02383251
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer treatment 2 completed NCT01081951
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer treatment 2 active_not_recruiting NCT01459653
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor No drug interventions Not Available Not Available completed NCT01367353
Characterization of Ovarian Cancer Stem Cell No drug interventions basic_science Not Available unknown_status NCT02567253
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer treatment 2 completed NCT00189553
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse treatment 3 completed NCT00510653
Gleevec Study for Patients With Ovarian Cancer treatment 2 completed NCT05748353
Endocrine Disruptors and Life STILe in Breast Cancer Development No drug interventions Not Available Not Available active_not_recruiting NCT04248153
Optimal Timing of BR55 CEUS of the Ovaries No drug interventions diagnostic 2 terminated NCT00877253
Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer treatment 1 completed NCT00004177
Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer treatment 1 / 2 completed NCT01219777
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian treatment 1 completed NCT06298877
Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer No drug interventions other Not Available recruiting NCT00091377
Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 completed NCT02346747
A Trial of Vigil for Participants With Ovarian Cancer No drug interventions treatment 2 active_not_recruiting NCT00959647
A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study treatment 2 completed NCT06251947
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen treatment 2 recruiting NCT05258747
A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer other 1 completed NCT03814447
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer treatment 0 unknown_status NCT02530047
Mesenchymal Stem Cells (MSC) for Ovarian Cancer No drug interventions treatment 1 completed NCT05185947
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer treatment 2 recruiting NCT05824247
A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT00655447
Examining the Long-Term Risks of Oophorectomy No drug interventions Not Available Not Available completed NCT01042847
How Our Immune System Can Help Fight Cancer No drug interventions Not Available Not Available completed NCT03414047
A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer treatment 2 completed NCT01743547
The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study No drug interventions supportive_care Not Available terminated NCT05420545
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04881045
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. No drug interventions treatment 1 completed NCT00189345
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients treatment 2 completed NCT00782145
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families No drug interventions supportive_care 3 completed NCT06109545
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy No drug interventions Not Available Not Available recruiting NCT00753545
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer treatment 2 completed NCT00005645
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment treatment 2 withdrawn NCT01690598
Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status treatment 1 / 2 completed NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) No drug interventions Not Available Not Available unknown_status NCT03054298
CAR T Cells in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT01538498
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer No drug interventions Not Available Not Available completed NCT01669798
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer treatment 2 completed NCT05697198
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine No drug interventions Not Available Not Available recruiting NCT01074398
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 No drug interventions Not Available Not Available unknown_status NCT06293898
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT02917798
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes No drug interventions Not Available Not Available recruiting NCT00772798
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer treatment 2 unknown_status NCT00003998
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer treatment 3 completed NCT03323398
Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies treatment 1 / 2 terminated NCT02305498
Yoga Practice for Breast or Ovarian Cancer Patients No drug interventions treatment Not Available completed NCT06240598
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy No drug interventions diagnostic 2 recruiting NCT05363605
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours treatment 1 / 2 terminated NCT01493505
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer treatment 3 terminated NCT00033605
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis supportive_care 3 completed NCT00703105
Ovarian Dendritic Cell Vaccine Trial No drug interventions treatment 2 unknown_status NCT01376505
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors treatment 1 completed NCT04999605
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT02317705
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer other 2 completed NCT06303505
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC No drug interventions treatment 1 / 2 recruiting NCT04803305
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia treatment 1 completed NCT00866697
Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT05746897
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04169997
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer No drug interventions treatment 3 unknown_status NCT00003297
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer treatment 1 / 2 completed NCT03378297
IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC basic_science 0 completed NCT06483997
Diet, Hepcidin, and Chemotherapy RDI No drug interventions Not Available Not Available recruiting NCT02952183
Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors No drug interventions Not Available Not Available unknown_status NCT01679483
Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer treatment Not Available completed NCT00001383
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 treatment 1 completed NCT05801783
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer No drug interventions treatment 0 recruiting NCT01471483
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04525183
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue No drug interventions supportive_care Not Available active_not_recruiting NCT00553683
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer treatment 1 / 2 unknown_status NCT02278783
Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer treatment 2 terminated NCT05251883
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics No drug interventions Not Available Not Available recruiting NCT05103683
First in Human Study of TORL-1-23 in Participants With Advanced Cancer No drug interventions treatment 1 recruiting NCT03881683
Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer No drug interventions diagnostic Not Available completed NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT06458361
Identification of Risk Factors and Construction of Prediction Model for Postoperative Intestinal Anastomotic Leakage in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT04575961
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer treatment 2 recruiting NCT01357161
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) treatment 2 completed NCT04066361
OPTimizing Treatment Focused Genetic Testing IN Cancer No drug interventions supportive_care Not Available completed NCT00505661
Letrozole in Patients With Ovarian Tumors treatment 2 terminated NCT04201561
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy prevention 3 active_not_recruiting NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma treatment 1 recruiting NCT01172028
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT03980028
Role of Surgery in Advanced Ovarian Cancer No drug interventions Not Available Not Available completed NCT01851928
Validation of a Nutrition Screening Tool No drug interventions Not Available Not Available completed NCT05300828
Safety of Genexol PM and Carboplatin as First-line Therapy in Ovarian Cancer No drug interventions Not Available Not Available completed NCT02865811
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer treatment 2 completed NCT05489211
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) treatment 2 recruiting NCT03508011
A Study of IMP4297 in Patients With Advanced Solid Tumors treatment 1 completed NCT00390611
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer treatment 2 completed NCT05749211
Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer treatment Not Available not_yet_recruiting NCT02144311
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics No drug interventions diagnostic Not Available completed NCT04204811
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy No drug interventions Not Available Not Available active_not_recruiting NCT03675893
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Zotatifin in Endometrial or Low-Grade Serous Ovarian Cancer treatment 2 recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT01863693
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) No drug interventions Not Available Not Available completed NCT01624493
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients treatment 1 / 2 withdrawn NCT00418093
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma treatment 2 terminated NCT00837993
Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System No drug interventions Not Available Not Available completed NCT00293293
Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine supportive_care Not Available completed NCT03203993
China Ovarian Cancer BRCA Testing Study No drug interventions Not Available Not Available terminated NCT01469793
A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer No drug interventions treatment 1 completed NCT06161493
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors treatment 1 recruiting NCT03287271
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK treatment 1 / 2 recruiting NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers treatment 1 recruiting NCT06541171
A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results No drug interventions Not Available Not Available not_yet_recruiting NCT00002671
Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer treatment 2 completed NCT06459271
Feasibility of CALM in Patients With Ovarian Cancer No drug interventions supportive_care Not Available recruiting NCT01358071
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer treatment 2 completed NCT01402271
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer treatment 1 / 2 completed NCT01137071
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 terminated NCT02000778
EC17 for Intraoperative Imaging in Occult Ovarian Cancer diagnostic 1 completed NCT02017678
Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin treatment 2 withdrawn NCT04024878
NeoVax With Nivolumab in Patients With Ovarian Cancer treatment 1 active_not_recruiting NCT01684878
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) treatment 3 completed NCT00003378
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer treatment 1 terminated NCT06515678
Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension Not Available Not Available active_not_recruiting NCT00003778
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma treatment 2 completed NCT00093678
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer supportive_care Not Available withdrawn NCT02327078
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) treatment 1 / 2 completed NCT00531778
NYU Ovarian Cancer Early Detection Program Blood and Genetics No drug interventions Not Available Not Available terminated NCT00508378
Chemotherapy-Related Toxicities In Ovarian Cancer Patients No drug interventions Not Available Not Available completed NCT05099978
Asian Multicenter Prospective Study of ctDNA Sequencing No drug interventions Not Available Not Available active_not_recruiting NCT01523678
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers prevention 2 completed NCT03784378
Continued Access to RXDX-105 treatment 1 completed NCT00381888
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer treatment 2 completed NCT00181688
Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer treatment 2 completed NCT04145388
Family History Study on Cancer Risk No drug interventions health_services_research Not Available active_not_recruiting NCT00579488
Clinical Significance of Germline BRCA Mutations No drug interventions Not Available Not Available active_not_recruiting NCT02132988
Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer treatment 2 unknown_status NCT03321188
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients treatment 2 recruiting NCT00617188
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer treatment 2 completed NCT00003588
Gene Therapy in Treating Patients With Ovarian Cancer No drug interventions treatment 1 completed NCT00312988
Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy treatment 3 completed NCT02421588
Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients treatment 3 completed NCT00303888
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 1 terminated NCT01705288
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study supportive_care 0 completed NCT02039388
Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma No drug interventions diagnostic Not Available completed NCT00113607
An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer treatment 3 completed NCT00926107
Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse treatment 2 terminated NCT05226507
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer No drug interventions treatment 1 recruiting NCT05490407
Role of the ATP7A Transporter in Ovarian Cancer screening Not Available completed NCT00699907
Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer prevention 2 completed NCT05903807
[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer No drug interventions diagnostic 2 recruiting NCT05123807
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) No drug interventions treatment 2 recruiting NCT03561207
3D Prediction of Patient-Specific Response No drug interventions Not Available Not Available active_not_recruiting NCT00486707
Ovarian Cancer Patient Questionnaire on Genetic Testing No drug interventions Not Available Not Available completed NCT04460807
Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer treatment 3 terminated NCT03180307
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer other 3 completed NCT00005807
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer treatment 1 completed NCT03656809
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT04608409
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer treatment 1 active_not_recruiting NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret No drug interventions Not Available Not Available recruiting NCT06120309
New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT00097409
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer treatment 2 completed NCT05856409
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence No drug interventions Not Available Not Available recruiting NCT00345709
Elizabeth Registry for Low Grade Ovarian Cancer No drug interventions Not Available Not Available completed NCT01017809
Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer prevention Not Available withdrawn NCT03526809
Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology No drug interventions Not Available Not Available unknown_status NCT01268956
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis No drug interventions Not Available Not Available unknown_status NCT00838656
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 unknown_status NCT04235556
Integrated Care Pathway in Oncology (PASSION) No drug interventions Not Available Not Available unknown_status NCT06180356
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression treatment 2 recruiting NCT00964756
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers treatment 1 completed NCT00806156
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer treatment 2 completed NCT00049556
Gefitinib in Treating Patients With Cervical Cancer treatment 2 completed NCT04282356
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer No drug interventions treatment 2 recruiting NCT02867956
Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer treatment 2 completed NCT00005956
Biological Therapy in Treating Patients With Advanced Cancer No drug interventions treatment Not Available completed NCT04375956
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients treatment 2 recruiting NCT05740956
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00287885
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer treatment 1 completed NCT02042885
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 terminated NCT02389985
A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT02470585
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 terminated NCT03394885
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer treatment 1 / 2 completed NCT00021385
Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer treatment 2 unknown_status NCT00562185
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer treatment 1 / 2 withdrawn NCT03119285
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families No drug interventions Not Available Not Available completed NCT02118285
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 completed NCT04891185
Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer diagnostic 2 terminated NCT03266185
Shorter Scalp Cooling Time in Paclitaxel No drug interventions supportive_care Not Available completed NCT02661815
A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer treatment 1 terminated NCT05104515
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine No drug interventions treatment 1 recruiting NCT02179515
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) treatment 1 completed NCT01482715
A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) treatment 1 / 2 completed NCT05410015
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT02854215
Cost Utility of Radical Surgery in Ovarian Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT01824615
Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma treatment 2 completed NCT01334437
Blood Test for Ovarian Cancer Associated Auto Antibodies No drug interventions Not Available Not Available unknown_status NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer treatment 2 recruiting NCT01166737
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer No drug interventions other Not Available completed NCT06543537
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer No drug interventions health_services_research Not Available not_yet_recruiting NCT02560337
Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. treatment 2 completed NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors treatment 1 terminated NCT02681237
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer treatment Not Available completed NCT00017537
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer No drug interventions treatment 1 withdrawn NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT00291837
CT-2106 for the Second Line Treatment of Ovarian Cancer No drug interventions treatment 2 completed NCT01239732
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer treatment 3 completed NCT00003732
Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer treatment 2 completed NCT00321932
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant treatment 2 completed NCT01696032
SGI-110 in Combination With Carboplatin in Ovarian Cancer treatment 2 completed NCT00055432
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer treatment 2 terminated NCT04545632
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor No drug interventions Not Available Not Available completed NCT01306032
Phase II ABT-888 With Cyclophosphamide treatment 2 completed NCT00471432
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors treatment 1 completed NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 unknown_status NCT00608452
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers No drug interventions Not Available Not Available completed NCT00165152
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing No drug interventions Not Available Not Available completed NCT04284852
Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting treatment 2 completed NCT02758652
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02367352
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors treatment 1 terminated NCT00019552
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00842452
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT00423852
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin treatment 1 / 2 completed NCT05395052
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors treatment 1 terminated NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT01163552
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity No drug interventions treatment 2 completed NCT00478452
Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients treatment 1 completed NCT00340600
Continuation of Follow-up of DES-Exposed Cohorts No drug interventions Not Available Not Available completed NCT03430700
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 active_not_recruiting NCT02307500
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy treatment 2 completed NCT00002600
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer treatment 1 completed NCT00910000
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer treatment 1 / 2 terminated NCT00460200
Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer No drug interventions Not Available Not Available withdrawn NCT00098800
Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries prevention Not Available completed NCT03840200
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. treatment 1 completed NCT00692900
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer treatment 1 completed NCT00118300
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer treatment 1 withdrawn NCT03038100
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 3 completed NCT05460000
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy No drug interventions treatment 2 not_yet_recruiting NCT01091259
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer treatment 2 completed NCT05292859
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs No drug interventions Not Available Not Available active_not_recruiting NCT01888159
Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve No drug interventions prevention Not Available unknown_status NCT00002559
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin treatment 1 / 2 completed NCT03188159
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer treatment 2 unknown_status NCT01196559
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer treatment 2 completed NCT00287859
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 1 terminated NCT01439659
Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer No drug interventions treatment 2 active_not_recruiting NCT00039559
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer No drug interventions screening Not Available unknown_status NCT06065059
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors treatment 1 / 2 terminated NCT00045175
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer treatment 1 completed NCT04814875
A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy treatment 1 / 2 terminated NCT06032975
PRO for Fighting FT in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT02948075
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy treatment 2 completed NCT00102375
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer treatment 3 completed NCT06283875
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT00050375
Clinical Trial for Ovarian Cancer (OvaRex®) treatment 3 terminated NCT00231075
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV treatment 2 completed NCT01709175
Strength Training Study for Survivors of Breast and Gynecologic Cancer No drug interventions screening Not Available completed NCT05886075
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors No drug interventions treatment 0 recruiting NCT03547375
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy treatment 2 unknown_status NCT06010875
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT04617470
Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study No drug interventions Not Available Not Available unknown_status NCT05429970
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) prevention Not Available recruiting NCT00003670
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer treatment 2 completed NCT04625270
A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation treatment 2 active_not_recruiting NCT00084370
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy prevention Not Available withdrawn NCT00408070
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 terminated NCT00238342
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass No drug interventions diagnostic Not Available unknown_status NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT03249142
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer treatment 1 / 2 active_not_recruiting NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd) No drug interventions Not Available Not Available recruiting NCT00138242
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer treatment 2 completed NCT00693342
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission treatment 3 withdrawn NCT00230542
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer treatment 2 completed NCT00928642
Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer treatment 2 completed NCT04898842
Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet No drug interventions treatment Not Available completed NCT00702299
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer treatment 1 completed NCT01670799
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer other 0 completed NCT00006099
Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer diagnostic 1 terminated NCT01170299
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer No drug interventions supportive_care Not Available completed NCT00526799
Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer treatment 1 / 2 terminated NCT00652899
Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 terminated NCT00849199
Cancer Screening and Prevention Program for High Risk Women No drug interventions Not Available Not Available completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT05877599
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation No drug interventions treatment 1 recruiting NCT03779399
Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor No drug interventions Not Available Not Available completed NCT00986206
Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer No drug interventions Not Available Not Available completed NCT02489006
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer treatment 2 active_not_recruiting NCT06203106
NYSCF Scientific Discovery Biobank No drug interventions Not Available Not Available recruiting NCT04875806
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 terminated NCT05342506
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies treatment 2 unknown_status NCT00001806
Methods in Education for Breast Cancer Genetics No drug interventions health_services_research 3 completed NCT01582906
A Survivorship Care Plan for Gynaecological Cancer Patients No drug interventions Not Available Not Available completed NCT00844506
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer treatment 2 completed NCT00987649
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass No drug interventions Not Available Not Available completed NCT04817449
Spectroscopy in Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT01544049
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study No drug interventions Not Available Not Available completed NCT03806049
Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer treatment 3 withdrawn NCT03149549
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors treatment 1 / 2 terminated NCT05921149
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer treatment Not Available not_yet_recruiting NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions health_services_research Not Available not_yet_recruiting NCT00526149
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors treatment 2 completed NCT00003449
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer treatment 2 completed NCT05926336
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action treatment 4 recruiting NCT01618136
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors treatment 1 / 2 completed NCT01689636
Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients No drug interventions other 1 completed NCT04102436
Non-Viral TCR Gene Therapy treatment 2 withdrawn NCT01242436
Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis No drug interventions diagnostic Not Available completed NCT02083536
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma treatment 1 withdrawn NCT03989336
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer treatment 2 completed NCT00005836
Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy treatment 2 completed NCT00019136
Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer treatment 1 completed NCT00003636
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 3 completed NCT01012336
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin treatment 2 completed NCT00862836
Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD) treatment 1 / 2 terminated NCT01968213
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) treatment 3 completed NCT00088413
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer treatment 1 / 2 completed NCT03326713
Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project No drug interventions prevention Not Available completed NCT02203513
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer treatment 2 terminated NCT00003413
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer treatment 2 completed NCT02607813
Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations treatment 1 terminated NCT02249013
Short-course HIPEC in Advanced Epithelial Ovarian Cancer treatment 2 completed NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT03799913
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer treatment 0 unknown_status NCT00712218
Lymphadenectomy In Ovarian Neoplasms No drug interventions treatment Not Available completed NCT00003518
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors treatment 2 completed NCT01739218
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable treatment 2 completed NCT00003718
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma treatment 2 unknown_status NCT00391118
Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") treatment 2 completed NCT00268918
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients treatment 1 completed NCT00746018
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy No drug interventions treatment Not Available completed NCT03901118
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer treatment 2 completed NCT05223218
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study No drug interventions Not Available Not Available enrolling_by_invitation NCT05683418
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors No drug interventions treatment 1 recruiting NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT01445418
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer treatment 1 completed NCT00097019
A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed treatment 2 completed NCT02287519
Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention No drug interventions supportive_care Not Available completed NCT01061619
Pathway to Diagnosis of Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT06433219
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) treatment 2 recruiting NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT00652119
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin treatment 1 unknown_status NCT01227941
MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) treatment 1 terminated NCT05476341
A Phase I Clinical Trial of Bevacizumab Injection treatment 1 completed NCT02719041
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study No drug interventions Not Available Not Available unknown_status NCT00073541
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer treatment 2 completed NCT00511641
Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01065441
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer No drug interventions treatment 1 / 2 completed NCT05965141
Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer treatment 1 / 2 not_yet_recruiting NCT00002641
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma treatment 3 completed NCT03335241
Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer treatment 2 unknown_status NCT00025441
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors treatment 2 completed NCT02869217
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors treatment 1 active_not_recruiting NCT00002717
Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer treatment 3 completed NCT02988817
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors treatment 1 / 2 completed NCT05769517
PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES No drug interventions Not Available Not Available recruiting NCT05265117
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study No drug interventions Not Available Not Available recruiting NCT04853017
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery treatment 3 active_not_recruiting NCT03278717
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients treatment 3 unknown_status NCT00526617
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients treatment 1 completed NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT04676334
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib treatment 3 completed NCT00002734
Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer treatment 1 completed NCT00191334
Gemcitabine in Ovarian Cancer treatment 2 completed NCT01149434
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers treatment 1 / 2 terminated NCT00023634
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer treatment 1 terminated NCT03554434
An Expanded Access Program for AM0010 (Pegilodecakin) Not Available Not Available no_longer_available NCT00021034
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 1 completed NCT00003334
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract treatment 2 completed NCT01010334
Comparison of Standard of Care or Treatment on Protocol No drug interventions Not Available Not Available terminated NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) No drug interventions Not Available Not Available recruiting NCT05708924
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 suspended NCT02830724
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers treatment 1 / 2 recruiting NCT03010124
Prognostic and Predictive Biomarkers in Ovarian Cancers No drug interventions basic_science Not Available recruiting NCT05989724
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05961124
Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer treatment 2 recruiting NCT00016224
Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer treatment 2 completed NCT02019524
Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients prevention 1 completed NCT02469116
Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma treatment 2 terminated NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT03709316
A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer No drug interventions treatment 3 unknown_status NCT03943316
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies No drug interventions Not Available Not Available recruiting NCT03667716
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. treatment 1 completed NCT03752216
NIraparib and Quality Of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. treatment 4 completed NCT05715216
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer treatment 2 recruiting NCT00019916
Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer treatment 1 / 2 completed NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT04785716
Real-life Use of Niraparib in a Patient Access Program in Norway Not Available Not Available completed NCT01226316
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules treatment 1 active_not_recruiting NCT06103916
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice No drug interventions Not Available Not Available recruiting NCT00003896
S9912 Combination Chemo in Stage III Ovarian Cancer, treatment 2 completed NCT04795596
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers No drug interventions treatment 2 / 3 withdrawn NCT00720096
Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan treatment Not Available terminated NCT05377996
A Study of XMT-1660 in Participants With Solid Tumors No drug interventions treatment 1 recruiting NCT05801796
Appraising Medical Trial Experiences of Ovarian Cancer Patients No drug interventions Not Available Not Available not_yet_recruiting NCT04997096
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy No drug interventions supportive_care Not Available recruiting NCT00463996
MRI in Staging Ovarian Cancer Using MRI Contrast Agent No drug interventions Not Available Not Available unknown_status NCT00155896
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT00267696
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 completed NCT01880996
Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies No drug interventions treatment 1 / 2 withdrawn NCT03877796
Clinical Pre-screening Protocol for Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06216496
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer No drug interventions basic_science Not Available recruiting NCT03940196
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) treatment 3 completed NCT01705158
Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum treatment 1 / 2 completed NCT00776958
Lynne Cohen Consortium Project: Multi-Center Database/Registry No drug interventions Not Available Not Available completed NCT00189358
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy treatment 2 completed NCT01035658
Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma treatment 1 / 2 terminated NCT00024258
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors treatment 2 completed NCT02043158
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04849858
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures treatment 3 terminated NCT05805358
Hyperpolarized 13C MRI for Cancer Immunotherapy No drug interventions health_services_research 2 not_yet_recruiting NCT02321735
DOD Long-Term Survivors of Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01470235
Hypodontia and Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT04586335
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. treatment 1 terminated NCT04751435
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients No drug interventions health_services_research Not Available recruiting NCT00003135
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer treatment 2 unknown_status NCT01296035
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer treatment 2 terminated NCT05605535
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer treatment 2 recruiting NCT00058435
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer treatment 1 completed NCT00155935
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen No drug interventions diagnostic Not Available unknown_status NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT00006235
Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT00757263
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom No drug interventions Not Available Not Available unknown_status NCT05092763
Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer No drug interventions supportive_care Not Available recruiting NCT06451263
Nudge to Gynecologic Oncology No drug interventions supportive_care Not Available active_not_recruiting NCT02686463
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy No drug interventions treatment Not Available unknown_status NCT00587886
Estrogen, Diet, Genetics and Endometrial Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02354586
A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens treatment 2 completed NCT06071286
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS No drug interventions diagnostic Not Available recruiting NCT01583686
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer treatment 1 / 2 terminated NCT05448586
Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? No drug interventions Not Available Not Available completed NCT04918186
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer treatment 2 recruiting NCT04570839
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. treatment 1 / 2 completed NCT04334239
Effectiveness of Care in Certified Cancer Centres in Germany No drug interventions Not Available Not Available completed NCT05848739
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors treatment 1 recruiting NCT04352439
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy prevention 4 completed NCT01131039
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 withdrawn NCT03979339
Feasibility of a New Technology for Isolating Circulating Tumour Cells No drug interventions other Not Available unknown_status NCT05011539
Thiol-disulfide Homeostasis in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00080639
CA-125 in Screening Patients at High Risk for Ovarian Cancer No drug interventions Not Available Not Available withdrawn NCT05358639
Combination of Olaparib and Navitoclax in Women With HGSC and TNBC treatment 1 recruiting NCT00945139
Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA) treatment 2 completed NCT04267939
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer other 1 terminated NCT00582322
Genetic Studies in Breast Cancer No drug interventions Not Available Not Available completed NCT05043922
A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma No drug interventions treatment 2 unknown_status NCT03132922
MAGE-A4ᶜ¹º³²T for Multi-Tumor No drug interventions treatment 1 active_not_recruiting NCT05059522
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing treatment 3 active_not_recruiting NCT03229122
Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA No drug interventions Not Available Not Available completed NCT01370122
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies No drug interventions Not Available Not Available completed NCT00331422
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 terminated NCT02910622
Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer. No drug interventions Not Available Not Available completed NCT00003322
Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer treatment 3 completed NCT02878122
Study of Predictive Factors of Chemoresistance in Ovarian Cancer No drug interventions Not Available Not Available completed NCT06483425
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05453825
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors treatment 2 recruiting NCT03073525
A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers treatment 2 completed NCT00005025
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer treatment 2 unknown_status NCT01644825
Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer treatment 2 completed NCT01521325
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers basic_science 1 completed NCT00170625
Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer treatment 1 / 2 completed NCT02387125
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 treatment 1 terminated NCT02440425
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer treatment 2 completed NCT00788125
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors treatment 1 / 2 terminated NCT02667925
Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin treatment Not Available withdrawn NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer treatment 1 / 2 active_not_recruiting NCT00327925
Blood Test for Ovarian Cancer Associated Antibodies (CAAb) No drug interventions Not Available Not Available unknown_status NCT01309230
A Trial of FANG™ Vaccine for Participants With Ovarian Cancer No drug interventions treatment 2 completed NCT05431530
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03776630
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors No drug interventions diagnostic Not Available active_not_recruiting NCT03519230
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer treatment 3 active_not_recruiting NCT03831230
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response No drug interventions Not Available Not Available recruiting NCT04368130
SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care No drug interventions supportive_care Not Available withdrawn NCT05904730
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations treatment 1 enrolling_by_invitation NCT00006230
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer treatment 2 completed NCT05870748
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 treatment 2 / 3 recruiting NCT00319748
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers No drug interventions treatment 2 completed NCT05848648
PPK Study Based on Quantitative Pharmacology in Patients With Pamipril No drug interventions Not Available Not Available recruiting NCT02558348
Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) treatment 1 / 2 terminated NCT01276548
A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer treatment 2 completed NCT00084448
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 terminated NCT00504257
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma treatment 2 completed NCT04714957
PITCHER (Peritoneal Carcinomatosis Heterogeneity) No drug interventions Not Available Not Available recruiting NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant supportive_care 2 completed NCT00003657
High-dose ICE With Amifostine treatment 2 completed NCT01113957
A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer treatment 2 completed NCT05211557
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer No drug interventions treatment 1 / 2 recruiting NCT00112957
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00569257
Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors treatment 2 completed NCT02948426
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 terminated NCT01185626
ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers No drug interventions supportive_care Not Available completed NCT05375526
Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT04553926
'OLAP' (OLAparib Regulatory Post-marketing Surveillance) No drug interventions Not Available Not Available recruiting NCT00323726
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study No drug interventions Not Available Not Available withdrawn NCT00338026
A Phase I Study of ECO-4601 in Patients With Advanced Cancer treatment 1 completed NCT00002526
Chemotherapy in Treating Patients With Advanced Sarcoma treatment 2 completed NCT00003926
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors supportive_care 1 terminated NCT00189566
Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse treatment 2 completed NCT03556566
Open Label Immunotherapy Trial for Ovarian Cancer No drug interventions treatment 2 unknown_status NCT00484666
Platinum-Resistant, Recurrent Epithelial Ovarian Cancer No drug interventions Not Available Not Available withdrawn NCT03858166
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer No drug interventions treatment 4 terminated NCT00004166
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy supportive_care 3 completed NCT02107066
Women's Activity and Lifestyle Study in Connecticut No drug interventions prevention 3 completed NCT00445965
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer No drug interventions treatment 2 completed NCT03045965
Hysterectomy and OPPortunistic SAlpingectomy No drug interventions prevention Not Available recruiting NCT04503265
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT01422265
Patient Reported Symptoms in Ovarian Cancer (PRECISION) No drug interventions Not Available Not Available completed NCT04752865
Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT02711865
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT03842865
Expanded Access of Vigil in Solid Tumors No drug interventions Not Available Not Available temporarily_not_available NCT03740165
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) treatment 3 active_not_recruiting NCT00686465
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study No drug interventions treatment Not Available completed NCT00002474
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer treatment 2 completed NCT01485874
Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer treatment 1 terminated NCT00401674
MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer treatment 2 completed NCT00418574
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients treatment 2 / 3 terminated NCT04520074
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) treatment 3 recruiting NCT01977274
Predictive Clinical and Biological Parameters in Gynecological Cancer No drug interventions basic_science Not Available recruiting NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT05305820
Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy No drug interventions health_services_research Not Available active_not_recruiting NCT06253520
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer treatment 1 recruiting NCT00003120
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission treatment 3 completed NCT00368420
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer No drug interventions Not Available Not Available completed NCT00801320
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer No drug interventions other Not Available completed NCT02163720
Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON) Not Available Not Available completed NCT03452982
Sentinel Lymph Node in Early Ovarian Cancer No drug interventions diagnostic 2 completed NCT03924882
Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer treatment 2 unknown_status NCT03367182
Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer Not Available Not Available completed NCT01570582
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 unknown_status NCT05233982
MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer treatment 2 recruiting NCT00003382
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer treatment 1 terminated NCT00043082
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer treatment 3 completed NCT05123482
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies treatment 1 / 2 recruiting NCT00959582
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) No drug interventions diagnostic 1 completed NCT03842982
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) No drug interventions treatment 3 recruiting NCT01823731
A Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis Index No drug interventions Not Available Not Available unknown_status NCT02009631
A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors other 1 completed NCT00527631
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer No drug interventions treatment 1 unknown_status NCT01975831
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab treatment 1 completed NCT05591131
Genetic Testing in African Americans No drug interventions health_services_research Not Available recruiting NCT03746431
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection No drug interventions treatment 1 / 2 recruiting NCT05684731
Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer No drug interventions treatment 1 recruiting NCT04724031
Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00003173
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors treatment 2 completed NCT02649673
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies treatment 1 terminated NCT00316173
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer treatment 2 completed NCT03364673
Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer No drug interventions supportive_care Not Available completed NCT00091273
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer treatment 1 completed NCT03427073
A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours treatment 1 terminated NCT05796973
Measuring Oncological Value of Exercise and Statin treatment 3 recruiting NCT01600573
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) treatment 1 / 2 unknown_status NCT00617773
Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT03837327
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy No drug interventions Not Available Not Available completed NCT04630327
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory No drug interventions Not Available Not Available completed NCT00129727
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) treatment 2 completed NCT00261027
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer treatment 2 completed NCT04294927
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention No drug interventions prevention Not Available recruiting NCT05597527
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer treatment 2 not_yet_recruiting NCT00085527
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer treatment 2 withdrawn NCT00284427
Safety of Antioxidants During GYN Cancer Care treatment 2 completed NCT03934827
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour treatment 1 unknown_status NCT01826227
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer No drug interventions diagnostic Not Available completed NCT04921527
Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer prevention 3 recruiting NCT02631876
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer treatment 3 completed NCT03082976
Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region No drug interventions Not Available Not Available completed NCT05983276
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer treatment 2 recruiting NCT02622776
Advanced Methods for Cancer Detection by Vaginal Screening No drug interventions screening Not Available completed NCT03367260
The Treatment Preferences of Women Diagnosed With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00003560
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 unknown_status NCT00525460
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function No drug interventions Not Available Not Available completed NCT06544460
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients No drug interventions treatment 2 not_yet_recruiting NCT05200260
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer treatment 2 not_yet_recruiting NCT02732860
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host No drug interventions Not Available Not Available recruiting NCT00004060
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors treatment 1 completed NCT04884360
D9319C00001- 1L OC Mono Global RCT treatment 3 active_not_recruiting NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration No drug interventions treatment 1 recruiting NCT00937560
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer treatment 2 completed NCT00002894
Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer treatment 3 completed NCT00003794
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer No drug interventions Not Available Not Available terminated NCT00173394
The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients No drug interventions Not Available Not Available unknown_status NCT04878094
A Study of Intra-operative Imaging in Women With Ovarian Cancer No drug interventions diagnostic 3 recruiting NCT03275194
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy No drug interventions treatment 2 recruiting NCT00250094
Clinical Benefit of Topoisomerase Downregulation treatment 1 completed NCT01096394
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer No drug interventions Not Available Not Available completed NCT00432094
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors treatment 2 completed NCT00604994
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer No drug interventions Not Available Not Available completed NCT05170594
A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer treatment 2 unknown_status NCT00532194
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer treatment 3 unknown_status NCT00325494
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer treatment 1 completed NCT00474994
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas treatment 2 completed NCT03166891
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer treatment 1 / 2 completed NCT01047891
Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer treatment 2 completed NCT00652691
Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer treatment 1 completed NCT03004391
Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 No drug interventions Not Available Not Available completed NCT06379191
The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program No drug interventions health_services_research Not Available completed NCT05044091
Homologous Recombination Deficiency in Chinese Ovarian Cancer Patients Not Available Not Available unknown_status NCT01567891
CT Antigen TCR-redirected T Cells for Ovarian Cancer. No drug interventions treatment 1 / 2 completed NCT00721162
Study of Ramucirumab in Ovarian Cancer treatment 2 completed NCT03075462
A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients treatment 1 completed NCT00410462
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma treatment 2 unknown_status NCT00539162
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women No drug interventions screening Not Available recruiting NCT02178462
Biomarkers for Gynecologic Cancer No drug interventions Not Available Not Available unknown_status NCT05815862
Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer No drug interventions treatment 2 recruiting NCT03286062
VM110 in Detection of Microscopic Tumors: A Phase I Study No drug interventions diagnostic 1 terminated NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies treatment 1 completed NCT02873962
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib treatment 2 active_not_recruiting NCT00709462
A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) No drug interventions treatment 1 completed NCT02877862
Mobile Phone Technology to Increase Genetic Counseling No drug interventions health_services_research Not Available completed NCT00006262
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer treatment 2 terminated NCT03695380
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer treatment 1 completed NCT04640480
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors treatment 1 not_yet_recruiting NCT03395080
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma treatment 2 completed NCT00523380
Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer treatment 2 completed NCT05360680
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers No drug interventions treatment 1 active_not_recruiting NCT00003880
Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer treatment 2 / 3 terminated NCT00239980
Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) treatment 2 completed NCT03735680
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer diagnostic 2 completed NCT04503980
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors No drug interventions treatment 0 unknown_status NCT00403429
MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer treatment 2 completed NCT00005029
Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 terminated NCT00066729
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT01505829
Diffusion-weighted Imaging Study in Cancer of the Ovary No drug interventions Not Available Not Available completed NCT03587129
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer treatment 2 terminated NCT00217529
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer treatment 1 / 2 completed NCT00377429
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy treatment 2 completed NCT01441089
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis No drug interventions Not Available Not Available recruiting NCT03162289
Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers No drug interventions supportive_care Not Available active_not_recruiting NCT00900289
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer No drug interventions Not Available Not Available unknown_status NCT00872989
S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT05116189
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65) treatment 3 active_not_recruiting NCT05868889
Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD Not Available Not Available completed NCT01379989
INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer treatment 3 completed NCT03267589
Trial in Patients With Relapsed Ovarian Cancer treatment 2 completed NCT02664389
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation No drug interventions diagnostic Not Available completed NCT01312389
A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT01831089
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors treatment 1 completed NCT05156892
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer treatment 1 recruiting NCT00086892
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer treatment 2 completed NCT01033292
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer treatment 2 completed NCT03000192
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life No drug interventions Not Available Not Available unknown_status NCT00545792
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers treatment 2 completed NCT06394492
SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer treatment 3 recruiting NCT02399592
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer treatment 2 completed NCT03808792
Imaging Study in Advanced Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT03689192
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors No drug interventions treatment 1 completed NCT00343044
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers treatment 2 completed NCT05537844
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma No drug interventions Not Available Not Available recruiting NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT00768144
Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma treatment 2 completed NCT00003944
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT01691144
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project No drug interventions Not Available Not Available completed NCT01891344
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) treatment 2 completed NCT00436644
Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin treatment 2 completed NCT00596544
Sexual Functioning After Primary Treatment of Ovarian Cancer No drug interventions Not Available Not Available terminated NCT00944944
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema No drug interventions Not Available Not Available completed NCT05273944
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients treatment 1 unknown_status NCT00003644
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer treatment 3 completed NCT00001944
Vinorelbine and XR9576 to Treat Cancer treatment 1 completed NCT01262040
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive No drug interventions diagnostic Not Available completed NCT01246440
Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission treatment 2 completed NCT00610740
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer treatment 2 completed NCT05184140
Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer No drug interventions diagnostic Not Available recruiting NCT04528940
Tumor Grade Determines PD-1/PDL-1 Expression No drug interventions Not Available Not Available unknown_status NCT00562640
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) treatment 1 completed NCT00345540
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer treatment 2 completed NCT04396340
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b No drug interventions treatment 1 terminated NCT00072267
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT00070967
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer No drug interventions treatment 2 completed NCT00006267
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 withdrawn NCT01237067
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers treatment 1 completed NCT06184867
Choices About Genetic Testing And Learning Your Risk With Smart Technology No drug interventions health_services_research 0 recruiting NCT01572467
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors No drug interventions Not Available Not Available completed NCT00477867
Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172 No drug interventions health_services_research Not Available withdrawn NCT00003967
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT06377267
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) treatment 2 recruiting NCT00849667
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse treatment 3 terminated NCT00063401
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer treatment 2 completed NCT03464201
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study treatment 2 completed NCT05567601
Doxil/Caelyx BE Study treatment 1 completed NCT01177501
Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma treatment 1 terminated NCT00522301
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission treatment 2 terminated NCT03634501
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells No drug interventions treatment 1 / 2 unknown_status NCT00002901
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function treatment 1 completed NCT00684801
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers No drug interventions Not Available Not Available completed NCT00354601
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer treatment 2 terminated NCT04939701
Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants No drug interventions treatment 1 / 2 terminated NCT05371301
Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer treatment 3 unknown_status NCT01440504
Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors No drug interventions Not Available Not Available completed NCT00004604
Biological Therapy in Treating Patients With Metastatic Cancer No drug interventions treatment 1 completed NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer treatment 1 / 2 active_not_recruiting NCT00003772
Quality-of-Life Assessment in Patients With Ovarian Cancer No drug interventions Not Available Not Available completed NCT00515372
Depression Treatment and Screening in Ovarian Cancer Patients No drug interventions treatment 1 active_not_recruiting NCT06120972
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency treatment 2 recruiting NCT00043472
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk No drug interventions Not Available Not Available completed NCT02475772
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis treatment 1 completed NCT03471572
Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India No drug interventions Not Available Not Available completed NCT01242072
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies No drug interventions treatment 1 unknown_status NCT03860272
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer treatment 1 recruiting NCT01591772
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer No drug interventions Not Available Not Available completed NCT00267072
Ovarian Screening Study No drug interventions Not Available Not Available completed NCT06129968
Transforming Ovarian Cancer Diagnostic Pathways No drug interventions Not Available Not Available recruiting NCT03997968
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT01690468
PTX-200 and Carboplatin in Ovarian Cancer treatment 1 / 2 terminated NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies treatment 1 / 2 recruiting NCT01715168
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer treatment 1 unknown_status NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms treatment 1 completed NCT04458168
Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living No drug interventions supportive_care Not Available completed NCT01256268
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids treatment 1 completed NCT01661868
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer treatment 2 withdrawn NCT01087268
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer No drug interventions supportive_care 3 unknown_status NCT03942068
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT02069769
Ensuring Communication in Hospice by Oncology Study (ECHO) No drug interventions supportive_care Not Available completed NCT05129969
Registry Platform Ovarian and Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT00803569
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers treatment 1 completed NCT04630769
FT516 and IL2 With Enoblituzumab for Ovarian Cancer treatment 1 completed NCT01738269
Elecsys HE4 Chinese Reference Value Study No drug interventions Not Available Not Available completed NCT01734746
Sentinel Node Detection in Clinical Early Stage Ovarian Cancer No drug interventions diagnostic Not Available completed NCT06127446
The Registry of Genetic Alterations of Taiwan Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05162846
Methods for Increasing Genetic Testing Uptake in Michigan No drug interventions health_services_research Not Available recruiting NCT06518746
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation No drug interventions prevention Not Available recruiting NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT01654146
ICON8: Weekly Chemotherapy in Ovarian Cancer treatment 3 unknown_status NCT00342446
A Follow-up Study of Women Evaluated and Treated for Infertility No drug interventions Not Available Not Available completed NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant supportive_care 2 terminated NCT02769546
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis No drug interventions Not Available Not Available terminated NCT00216112
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer treatment 2 completed NCT00028912
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00499512
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer No drug interventions Not Available Not Available unknown_status NCT04170712
Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers No drug interventions Not Available Not Available unknown_status NCT00846612
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer treatment 1 completed NCT03691012
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00004012
Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation No drug interventions supportive_care 2 unknown_status NCT04214210
The DIALOGUE Study: Swiss-Korean Billateral Collaboration No drug interventions screening Not Available recruiting NCT00340210
Extended Follow-up of Columbia, MO Serum Bank Participants No drug interventions Not Available Not Available completed NCT06412510
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT No drug interventions supportive_care 1 / 2 recruiting NCT06317610
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids No drug interventions Not Available Not Available recruiting NCT00799110
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod treatment 2 active_not_recruiting NCT01419210
Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer No drug interventions supportive_care Not Available completed NCT00419510
Genetic Counseling in African American Women No drug interventions Not Available Not Available completed NCT00090610
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer treatment 2 completed NCT00072410
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer treatment 1 completed NCT06036810
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy No drug interventions health_services_research Not Available recruiting NCT00322881
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer treatment 2 terminated NCT03596281
Pembrolizumab in Combination With Bevacizumab and Pegylated Liposomal Doxorubicin in Patients With Ovarian Cancer treatment 1 active_not_recruiting NCT01258881
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis No drug interventions Not Available Not Available unknown_status NCT01031381
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer treatment 2 completed NCT01096381
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor No drug interventions Not Available Not Available terminated NCT05739981
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 1 / 2 recruiting NCT00883181
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy No drug interventions Not Available Not Available completed NCT00002895
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 3 completed NCT04626895
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers No drug interventions prevention Not Available completed NCT06145295
The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life No drug interventions supportive_care Not Available completed NCT00003695
Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer No drug interventions treatment 3 completed NCT04000295
Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer treatment 3 unknown_status NCT04239014
A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment. treatment 2 withdrawn NCT00610714
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer treatment 2 completed NCT00102414
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer treatment 3 completed NCT04053114
MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii No drug interventions Not Available Not Available unknown_status NCT05427214
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy No drug interventions device_feasibility Not Available recruiting NCT00003214
Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer treatment 3 completed NCT01048814
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases No drug interventions Not Available Not Available completed NCT03761914
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers treatment 1 / 2 active_not_recruiting NCT06188455
Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer treatment 3 not_yet_recruiting NCT01511055
Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand diagnostic 2 terminated NCT00993655
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer treatment 2 completed NCT05931055
The Effectiveness of Liquid Biopsy in Differential Diagnosis and Early Screening of Epithelial Ovarian Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT02262455
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors treatment 1 completed NCT02476955
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole treatment 1 terminated NCT05450055
Intraperitoneal Lidocaine in Ovarian Cancer Surgery No drug interventions treatment Not Available not_yet_recruiting NCT02298855
Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer. No drug interventions supportive_care Not Available completed NCT00840450
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin treatment 2 terminated NCT00826150
Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer treatment 1 / 2 completed NCT00002750
Melphalan in Patients With Neoplastic Meningitis treatment 1 completed NCT00735150
Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk No drug interventions Not Available Not Available completed NCT05344950
Connecting Audio and Radio Sensing Systems to Improve Care at Home No drug interventions Not Available Not Available recruiting NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT02188550
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer treatment 2 unknown_status NCT00245050
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer supportive_care 3 completed NCT00020150
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors treatment 1 completed NCT00274950
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors treatment 3 unknown_status NCT01105650
Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer treatment 2 completed NCT01465750
Epidemiology of Ovarian Cancer in Taiwan No drug interventions Not Available Not Available unknown_status NCT02529150
WISER After Ovarian Cancer - Exercise Pilot Study No drug interventions supportive_care Not Available completed NCT02973750
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer No drug interventions Not Available Not Available completed NCT03790423
18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer No drug interventions diagnostic 1 completed NCT02247323
Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125 No drug interventions Not Available Not Available unknown_status NCT01033123
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer treatment 2 completed NCT04406623
Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer No drug interventions treatment 1 completed NCT00003523
Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum treatment 2 completed NCT02984423
FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study No drug interventions Not Available Not Available completed NCT03763123
A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. treatment 1 unknown_status NCT05827523
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (KOV-HIPEC-04) treatment 3 recruiting NCT06234423
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00536523
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions Not Available Not Available terminated NCT06019923
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05551208
Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi treatment 2 recruiting NCT06222008
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution No drug interventions Not Available Not Available recruiting NCT05187208
PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer treatment 4 not_yet_recruiting NCT00061308
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer treatment 2 completed NCT01350908
Study of Circulating Tumoral DNA in Ovarian Cancer No drug interventions other Not Available completed NCT04815408
PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer treatment 2 recruiting NCT00004008
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer treatment 2 completed NCT00030108
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy treatment 1 completed NCT06249308
Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC ) No drug interventions Not Available Not Available recruiting NCT01383408
Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection No drug interventions diagnostic 2 terminated NCT00305838
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen diagnostic 2 unknown_status NCT04055038
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) treatment 2 / 3 unknown_status NCT03134638
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors treatment 1 terminated NCT00002538
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers No drug interventions treatment 2 completed NCT01416038
Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT01003938
Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer treatment 2 terminated NCT05124743
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors No drug interventions Not Available Not Available suspended NCT06284343
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study No drug interventions Not Available Not Available not_yet_recruiting NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT00006043
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin treatment 2 completed NCT00620243
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. No drug interventions diagnostic 0 completed NCT03300843
Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer No drug interventions treatment 2 terminated NCT06063343
Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145 No drug interventions treatment 1 completed NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck treatment 2 completed NCT00028743
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 3 completed NCT04234243
HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up No drug interventions Not Available Not Available completed NCT03283943
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. treatment 1 unknown_status NCT03029403
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 active_not_recruiting NCT00001503
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease No drug interventions Not Available Not Available completed NCT00867503
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer treatment 2 completed NCT00562003
Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients No drug interventions treatment 1 completed NCT00017303
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer treatment 2 unknown_status NCT00003103
Chemotherapy in Treating Patients With Solid Tumors treatment 1 / 2 completed NCT01202890
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer treatment 1 terminated NCT00637390
A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. treatment 1 terminated NCT02480790
Venous Thromboembolic Complications in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT00014690
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 completed NCT00262990
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer treatment 3 completed NCT05261490
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer treatment 1 / 2 terminated NCT01997190
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion treatment 1 completed NCT01218490
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer No drug interventions other 3 suspended NCT02237690
Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer treatment 1 completed NCT06366490
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer No drug interventions treatment 1 not_yet_recruiting NCT00012090
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum treatment 2 completed NCT00277290
Study of XL999 in Patients With Previously Treated Ovarian Cancer treatment 2 terminated NCT00004064
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 unknown_status NCT02372864
Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy No drug interventions supportive_care Not Available completed NCT03493464
BR55 in Characterization of Ovarian Lesions No drug interventions diagnostic 2 active_not_recruiting NCT04679064
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment treatment 3 recruiting NCT00170664
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer treatment 2 completed NCT06447064
Cancer Loyalty Card Study 2 (CLOCS-2) No drug interventions Not Available Not Available recruiting NCT03585764
MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 1 terminated NCT04214964
Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study No drug interventions Not Available Not Available active_not_recruiting NCT00816764
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer No drug interventions treatment 1 completed NCT00003064
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 unknown_status NCT00004921
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery treatment 3 completed NCT03514121
FPA150 in Patients With Advanced Solid Tumors treatment 0 completed NCT04598321
BrUOG 390: Neoadjuvant Treatment With Talazoparib treatment 1 terminated NCT04470921
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands No drug interventions Not Available Not Available active_not_recruiting NCT03150121
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage No drug interventions diagnostic Not Available recruiting NCT00517621
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire treatment 2 completed NCT01744821
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer No drug interventions prevention Not Available terminated NCT05043402
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer treatment 3 unknown_status NCT03944902
CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients treatment 1 terminated NCT04502602
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer treatment 1 recruiting NCT00648102
Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer No drug interventions treatment 1 completed NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors No drug interventions Not Available Not Available completed NCT01386502
CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors treatment 1 withdrawn NCT04669002
EP0057 in Combination With Olaparib in Advanced Ovarian Cancer treatment 2 completed NCT03905902
DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma No drug interventions treatment 3 withdrawn NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT02608684
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer treatment 2 completed NCT06117384
Systems Oncology Approach to Optimize Ovarian Cancer Treatment No drug interventions Not Available Not Available recruiting NCT05475184
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor treatment 2 active_not_recruiting NCT00085384
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 terminated NCT00019084
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer treatment 2 completed NCT06476184
Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery treatment 3 recruiting NCT06321484
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer treatment 1 not_yet_recruiting NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant supportive_care Not Available completed NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT00550784
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 1 completed NCT06337084
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors No drug interventions diagnostic 1 recruiting NCT05183984
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer treatment 2 recruiting NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT01652079
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer treatment 2 completed NCT00158379
Taxol Carboplatin and Erythropoetin treatment 2 completed NCT00189579
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer treatment 2 terminated NCT03419884
A Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian Cancer treatment 3 not_yet_recruiting NCT03411486
Safety and Tolerability of a Modified Vaccinia Ankara (MVA) Priming Followed by Fowlpox Booster Vaccines Modified to Express Brachyury and T-Cell Costimulatory Molecules (MVA-BN-Brachyury/FPV-Brachyury) treatment 1 not_yet_recruiting NCT01565421
Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients treatment 2 withdrawn NCT02157870
A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer treatment 2 withdrawn NCT00436735
Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors treatment 1 active_not_recruiting